STOCK TITAN

CitroTech issues going-concern warning in Q3 2026

Quarterly revenue rose year over year, but nine-month revenue fell and operating cash use increased; management said available cash does not fund stated 12-month needs.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

CitroTech Inc. reported third-quarter revenue of $664,328 for the three months ended September 30, 2026, compared with $288,212 a year earlier, while nine-month revenue was $1,289,909, versus $1,945,232. Third-quarter net loss was $2,279,885, compared with $7,929,208; nine-month net loss was $12,393,003, compared with $30,736,631.

At September 30, 2026, CitroTech had $1,088,701 in cash and a $125.6 million accumulated deficit. It used $5,243,393 of cash in operating activities during the first nine months, versus $3,386,432 in the prior-year period. Management said cash, including October financing proceeds, was insufficient to fund commercial-scale production and related working capital for the next twelve months; these conditions raise substantial doubt about the company’s ability to continue as a going concern.

CitroTech’s October public offering closed October 22, 2026, and involved 2,240,000 common shares at $2.50 per share, producing approximately $5.2 million in net proceeds. Management said continuation depends on scaling commercial sales and that it may seek additional equity or debt financing.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointQuarterly revenue reached $664,328, versus $288,212 a year earlier.
  • Moderate pointNine-month net loss fell to $12,393,003 from $30,736,631.

Negative

  • Major pointManagement cited substantial doubt about continuation for one year following issuance.
  • Moderate pointNine-month revenue fell to $1,289,909 from $1,945,232.
  • Moderate pointOperating cash use rose to $5,243,393 from $3,386,432.

Filing Explained

A further four hundred sixty-seven thousand twelve Series C preferred shares are due to TCSI and may convert into common stock.

At September 30, 2026, CitroTech had 22,718,180 common shares outstanding, compared with 18,522,315 at December 31, 2025; it issued 4,195,865 common shares during the nine months. Those completed issuances increased the share count and reduced existing holders’ percentage ownership, absent offsetting changes.

The filing also reports 467,012 Series C preferred shares payable to TCSI 18 months after May 28, 2026, unless issued earlier under the specified change-of-control provision. Each Series C share may be converted at its holder’s option into 3.3333 common shares, so the preferred shares due represent a further potential source of common-share dilution.

Separately, the report lists 7,606,010 potential common-share equivalents, including warrants, preferred shares, performance stock units and restricted stock units; it excludes them from diluted loss per share because they were anti-dilutive.

Revenue $664,328 Three months ended September 30, 2026; $288,212 in 2025
Revenue $1,289,909 Nine months ended September 30, 2026; $1,945,232 in 2025
Net loss $12,393,003 loss Nine months ended September 30, 2026; $30,736,631 loss in 2025
Net cash used in operating activities $5,243,393 Nine months ended September 30, 2026; $3,386,432 in 2025
Cash $1,088,701 At September 30, 2026
Accumulated deficit $125.6 million At September 30, 2026
October public offering 2,240,000 common shares Offering closed October 22, 2026
Net proceeds Approximately $5.2 million October 2026 public offering
going concern financial
"substantial doubt about the Company's ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
working capital financial
"related working capital requirements for the next twelve months"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
deferred revenue financial
"Deferred revenue consists of advanced payments for our installation service"
Cash a company has already received for goods or services it has promised but not yet delivered; it's recorded as a liability because the company still owes that product, service, or future revenue recognition. For investors, deferred revenue signals upcoming work or deliveries that will convert into reported sales over time and affects short-term obligations, cash flow quality, and how quickly a firm can grow recognized revenue—think of it like prepaid subscriptions or gift cards a business must honor later.
anti-dilutive financial
"excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive"
A claim, security feature, or action described as anti-dilutive prevents or does not cause a reduction in existing shareholders’ per-share values when additional shares could be issued. For example, certain convertible securities or corporate actions are treated as anti-dilutive for earnings-per-share calculations if including them would raise EPS rather than lower it; investors watch this because it affects reported per-share metrics, ownership percentages, and valuation comparisons, like keeping pie slices the same size instead of making them smaller.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was CITR's revenue in Q3 2026?

CitroTech reported $664,328 in revenue for the three months ended September 30, 2026, compared with $288,212 in 2025. Product sales contributed $515,628 and product installation services contributed $148,700.

How much did CITR receive from its October 2026 offering?

The offering closed October 22, 2026, and involved 2,240,000 common shares at a public offering price of $2.50 per share. CitroTech reported approximately $5.2 million in net proceeds after underwriting discounts and other costs.

Why did CITR report substantial doubt about its ability to continue as a going concern?

At September 30, 2026, CitroTech had $1,088,701 in cash, $1.6 million in working capital, and a $125.6 million accumulated deficit. Management said cash, including the October financing proceeds, was insufficient to fund commercial-scale production and related working capital for the next twelve months.

How concentrated was CITR's customer revenue in Q3 2026?

Three customers each represented more than 10% of quarterly revenue, and the top five customers accounted for 58.6% of revenue for the three months ended September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 2026 Q3 0000894556 125596034 12393003 5243393 1 1 0000894556 2026-01-01 2026-09-30 0000894556 2026-11-10 0000894556 2026-09-30 0000894556 2025-12-31 0000894556 us-gaap:SeriesAPreferredStockMember 2026-09-30 0000894556 us-gaap:SeriesAPreferredStockMember 2025-12-31 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-12-31 0000894556 2026-07-01 2026-09-30 0000894556 2025-07-01 2025-09-30 0000894556 2025-01-01 2025-09-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-12-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-12-31 0000894556 us-gaap:CommonStockMember 2025-12-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000894556 us-gaap:RetainedEarningsMember 2025-12-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-03-31 0000894556 us-gaap:CommonStockMember 2026-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000894556 us-gaap:RetainedEarningsMember 2026-03-31 0000894556 2026-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-06-30 0000894556 us-gaap:CommonStockMember 2026-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000894556 us-gaap:RetainedEarningsMember 2026-06-30 0000894556 2026-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2024-12-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2024-12-31 0000894556 us-gaap:CommonStockMember 2024-12-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000894556 us-gaap:RetainedEarningsMember 2024-12-31 0000894556 2024-12-31 0000894556 CITR:SeriesAPreferredStocksMember 2025-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-03-31 0000894556 us-gaap:CommonStockMember 2025-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000894556 us-gaap:RetainedEarningsMember 2025-03-31 0000894556 2025-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2025-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-06-30 0000894556 us-gaap:CommonStockMember 2025-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000894556 us-gaap:RetainedEarningsMember 2025-06-30 0000894556 2025-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2026-01-01 2026-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-01-01 2026-03-31 0000894556 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000894556 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000894556 2026-01-01 2026-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-04-01 2026-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-04-01 2026-06-30 0000894556 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000894556 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000894556 2026-04-01 2026-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2026-07-01 2026-09-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-07-01 2026-09-30 0000894556 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0000894556 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-01-01 2025-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-01-01 2025-03-31 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000894556 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000894556 2025-01-01 2025-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2025-04-01 2025-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-04-01 2025-06-30 0000894556 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000894556 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000894556 2025-04-01 2025-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-07-01 2025-09-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-07-01 2025-09-30 0000894556 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000894556 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000894556 CITR:SeriesAPreferredStocksMember 2026-09-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-09-30 0000894556 us-gaap:CommonStockMember 2026-09-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0000894556 us-gaap:RetainedEarningsMember 2026-09-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-09-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-09-30 0000894556 us-gaap:CommonStockMember 2025-09-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000894556 us-gaap:RetainedEarningsMember 2025-09-30 0000894556 2025-09-30 0000894556 2026-10-01 2026-10-31 0000894556 CITR:CostOfInventoryMember 2026-07-01 2026-09-30 0000894556 CITR:CostOfInventoryMember 2025-07-01 2025-09-30 0000894556 CITR:CostOfInventoryMember 2026-01-01 2026-09-30 0000894556 CITR:CostOfInventoryMember 2025-01-01 2025-09-30 0000894556 CITR:FreightAndShippingMember 2026-07-01 2026-09-30 0000894556 CITR:FreightAndShippingMember 2025-07-01 2025-09-30 0000894556 CITR:FreightAndShippingMember 2026-01-01 2026-09-30 0000894556 CITR:FreightAndShippingMember 2025-01-01 2025-09-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2026-07-01 2026-09-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2025-07-01 2025-09-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2026-01-01 2026-09-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2025-01-01 2025-09-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2026-07-01 2026-09-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2025-07-01 2025-09-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2026-01-01 2026-09-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2025-01-01 2025-09-30 0000894556 CITR:RentExpenseMember 2026-07-01 2026-09-30 0000894556 CITR:RentExpenseMember 2025-07-01 2025-09-30 0000894556 CITR:RentExpenseMember 2026-01-01 2026-09-30 0000894556 CITR:RentExpenseMember 2025-01-01 2025-09-30 0000894556 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-09-30 0000894556 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-09-30 0000894556 us-gaap:WarrantMember 2026-01-01 2026-09-30 0000894556 us-gaap:WarrantMember 2025-01-01 2025-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockToBeIssuedMember 2026-01-01 2026-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockToBeIssuedMember 2025-01-01 2025-09-30 0000894556 CITR:PerformanceStockUnitsPSUsMember 2026-01-01 2026-09-30 0000894556 us-gaap:PhantomShareUnitsPSUsMember 2025-01-01 2025-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0000894556 CITR:ManagementCompensationMember 2026-07-01 2026-09-30 0000894556 CITR:ManagementCompensationMember 2025-07-01 2025-09-30 0000894556 CITR:ManagementCompensationMember 2026-01-01 2026-09-30 0000894556 CITR:ManagementCompensationMember 2025-01-01 2025-09-30 0000894556 CITR:ProfessionalFeesMember 2026-07-01 2026-09-30 0000894556 CITR:ProfessionalFeesMember 2025-07-01 2025-09-30 0000894556 CITR:ProfessionalFeesMember 2026-01-01 2026-09-30 0000894556 CITR:ProfessionalFeesMember 2025-01-01 2025-09-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2026-07-01 2026-09-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2025-07-01 2025-09-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2026-01-01 2026-09-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2025-01-01 2025-09-30 0000894556 CITR:FinancingExpenseMember 2026-07-01 2026-09-30 0000894556 CITR:FinancingExpenseMember 2025-07-01 2025-09-30 0000894556 CITR:FinancingExpenseMember 2026-01-01 2026-09-30 0000894556 CITR:FinancingExpenseMember 2025-01-01 2025-09-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2026-07-01 2026-09-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2025-07-01 2025-09-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2026-01-01 2026-09-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2025-01-01 2025-09-30 0000894556 CITR:InsuranceMember 2026-09-30 0000894556 CITR:InsuranceMember 2025-12-31 0000894556 CITR:LegalRetainerMember 2026-09-30 0000894556 CITR:LegalRetainerMember 2025-12-31 0000894556 CITR:ResearchAndDevelopmentExpensesMember 2026-09-30 0000894556 CITR:ResearchAndDevelopmentExpensesMember 2025-12-31 0000894556 CITR:AdvertisingAndMarketingMember 2026-09-30 0000894556 CITR:AdvertisingAndMarketingMember 2025-12-31 0000894556 CITR:OtherPrepaidOperatingExpensesMember 2026-09-30 0000894556 CITR:OtherPrepaidOperatingExpensesMember 2025-12-31 0000894556 CITR:DepositOnPurchaseOfInventoriesMember 2026-09-30 0000894556 CITR:DepositOnPurchaseOfInventoriesMember 2025-12-31 0000894556 us-gaap:EquipmentMember 2026-09-30 0000894556 us-gaap:EquipmentMember 2025-12-31 0000894556 us-gaap:VehiclesMember 2026-09-30 0000894556 us-gaap:VehiclesMember 2025-12-31 0000894556 CITR:SoftwareUnderDevelopmentMember 2026-09-30 0000894556 CITR:SoftwareUnderDevelopmentMember 2025-12-31 0000894556 us-gaap:EquipmentMember 2026-01-01 2026-09-30 0000894556 CITR:VehiclesAndEquipmentMember 2025-01-01 2025-09-30 0000894556 CITR:VehiclesAndEquipmentMember CITR:FinancedMember 2025-01-01 2025-09-30 0000894556 us-gaap:VehiclesMember 2025-01-01 2025-09-30 0000894556 CITR:VehiclesAndEquipmentMember 2026-01-01 2026-09-30 0000894556 CITR:OtherCurrentLiabilitySettledMember 2026-01-01 2026-09-30 0000894556 CITR:September2025VehicleMember 2025-09-01 2025-09-30 0000894556 CITR:September2025Vehicle1Member 2025-09-01 2025-09-30 0000894556 CITR:September2025VehicleMember 2026-01-01 2026-09-30 0000894556 CITR:FinancingLoanMember 2026-07-01 2026-09-30 0000894556 CITR:FinancingLoanMember 2025-07-01 2025-09-30 0000894556 CITR:FinancingLoanMember 2026-01-01 2026-09-30 0000894556 CITR:FinancingLoanMember 2025-01-01 2025-09-30 0000894556 us-gaap:IntellectualPropertyMember 2025-12-01 2025-12-31 0000894556 us-gaap:PatentsMember 2026-09-30 0000894556 us-gaap:PatentsMember 2025-12-31 0000894556 us-gaap:TechnologyBasedIntangibleAssetsMember 2026-09-30 0000894556 us-gaap:TechnologyBasedIntangibleAssetsMember 2025-12-31 0000894556 us-gaap:NoncompeteAgreementsMember 2026-09-30 0000894556 us-gaap:NoncompeteAgreementsMember 2025-12-31 0000894556 2025-01-31 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2026-09-30 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2026-01-01 2026-09-30 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2025-12-31 0000894556 CITR:ConvertibleNotesMember 2026-09-30 0000894556 CITR:ConvertibleNotesMember 2025-12-31 0000894556 CITR:ConvertibleNotesMember 2026-07-01 2026-09-30 0000894556 CITR:ConvertibleNotesMember 2025-07-01 2025-09-30 0000894556 CITR:ConvertibleNotesMember 2026-01-01 2026-09-30 0000894556 CITR:ConvertibleNotesMember 2025-01-01 2025-09-30 0000894556 CITR:ConvertibleNotesFeb2025Member CITR:NoteHolders7Member 2026-02-01 2026-02-28 0000894556 CITR:ConvertibleNotesFeb2025Member CITR:NoteHolders7Member 2026-02-28 0000894556 us-gaap:AccountsPayableMember 2026-09-30 0000894556 us-gaap:AccountsPayableMember 2025-12-31 0000894556 CITR:AccruedInterestPayableMember 2026-09-30 0000894556 CITR:AccruedInterestPayableMember 2025-12-31 0000894556 CITR:CreditCardPayableMember 2026-09-30 0000894556 CITR:CreditCardPayableMember 2025-12-31 0000894556 CITR:SalesTaxPayableMember 2026-09-30 0000894556 CITR:SalesTaxPayableMember 2025-12-31 0000894556 CITR:OtherLiabilityMember 2026-09-30 0000894556 CITR:OtherLiabilityMember 2025-12-31 0000894556 CITR:PayrollLiabilityMember 2026-09-30 0000894556 CITR:PayrollLiabilityMember 2025-12-31 0000894556 CITR:RelatedPartyAMember CITR:OperatingExpensesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyAMember CITR:OperatingExpensesMember 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyFMember CITR:ConvertibleNoteAccruedInterestRelatedPartyMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyFMember CITR:ConvertibleNoteAccruedInterestRelatedPartyMember 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyGMember CITR:ConsultingFeesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:ConsultingFeesMember 2025-01-01 2025-12-31 0000894556 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2026-07-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2025-07-01 2025-09-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2026-07-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2025-07-01 2025-09-30 0000894556 CITR:RelatedPartyAMember CITR:SeriesCPreferredStockForConsultingFeeMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyAMember CITR:SeriesCPreferredStockForConsultingFeeMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyCMember CITR:ConsultingAndAdvisoryFeesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyCMember CITR:ConsultingAndAdvisoryFeesMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyEMember CITR:ManagementCompensationMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyEMember CITR:ManagementCompensationMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2025-01-01 2025-09-30 0000894556 CITR:RelatedPartyAMember 2026-01-01 2026-09-30 0000894556 CITR:RelatedPartyGMember CITR:ConsultingFeesMember 2026-09-30 0000894556 CITR:RelatedPartyBMember 2026-02-01 2026-02-28 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member CITR:RelatedPartyFMember 2025-02-28 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member CITR:RelatedPartyFMember CITR:OIDAndFinancingFeeMember 2025-02-28 0000894556 2026-04-01 2026-04-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-04-01 2026-04-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-04-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-12-31 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2026-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2026-01-01 2026-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2025-12-31 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-07-01 2026-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-07-01 2025-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-01-01 2026-09-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-01-01 2025-09-30 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesAPreferredStockMember 2026-05-27 2026-05-28 0000894556 CITR:ExchangeAgreementsMember CITR:SeriesCConvertiblePreferredStockMember 2026-05-27 2026-05-28 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesCPreferredStockMember 2026-05-28 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesCPreferredStockMember 2026-05-27 2026-05-28 0000894556 us-gaap:SeriesCPreferredStockMember 2026-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember CITR:SecuritiesPurchaseAgreementsMember 2025-09-01 2025-09-30 0000894556 us-gaap:SeriesCPreferredStockMember CITR:Sept2025PipeOfferingMember 2025-09-01 2025-09-30 0000894556 CITR:Sept2025PipeWarrantsMember CITR:Sept2025PipeOfferingMember 2025-09-01 2025-09-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember CITR:SubscriptionsMember 2026-01-01 2026-09-30 0000894556 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0000894556 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0000894556 CITR:DebtConvertedIntoCommonStockMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0000894556 CITR:CashlessExerciseOfWarrantsMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0000894556 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-09-30 0000894556 CITR:DebtConvertedIntoCommonStockMember us-gaap:CommonStockMember 2025-01-01 2025-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefOperatingOfficerMember 2025-06-26 2025-06-27 0000894556 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember 2025-09-21 2025-09-22 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2026-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0000894556 CITR:FormerCEOAndCurrentChairmanMember CITR:ManagementCompensationPSUMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0000894556 CITR:ChairmanMember CITR:ManagementCompensationPSUMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0000894556 srt:ChiefOperatingOfficerMember CITR:ManagementCompensationPSUMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0000894556 srt:ChiefExecutiveOfficerMember CITR:ManagementCompensationPSUMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-09-30 0000894556 CITR:ManagementCompensationPSUMember 2026-01-01 2026-09-30 0000894556 CITR:ManagementCompensationPSUMember 2026-09-30 0000894556 srt:ChiefExecutiveOfficerMember CITR:SeriesCConvertiblePreferredStockMember 2026-09-30 0000894556 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2026-09-30 0000894556 srt:ChiefOperatingOfficerMember us-gaap:CommonStockMember 2026-09-30 0000894556 CITR:RelatedPartyFMember us-gaap:WarrantMember 2026-04-30 0000894556 CITR:RelatedPartyFMember us-gaap:WarrantMember 2026-04-01 2026-04-30 0000894556 CITR:ConsultantMember us-gaap:WarrantMember 2026-09-30 0000894556 CITR:ConsultantMember us-gaap:WarrantMember 2026-09-01 2026-09-30 0000894556 us-gaap:WarrantMember 2026-09-30 0000894556 CITR:WarrantsMember 2026-01-01 2026-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2026-07-01 2026-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0000894556 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0000894556 CITR:ManagementCompensationPSUMember 2026-07-01 2026-09-30 0000894556 CITR:ManagementCompensationPSUMember 2025-07-01 2025-09-30 0000894556 CITR:ManagementCompensationPSUMember 2025-01-01 2025-09-30 0000894556 CITR:CompensationAwardsMember 2025-01-01 2025-12-31 0000894556 srt:MinimumMember CITR:CompensationAwardsMember 2026-01-01 2026-09-30 0000894556 CITR:CompensationAwardsMember srt:MaximumMember 2026-01-01 2026-09-30 0000894556 CITR:CompensationAwardsMember srt:MinimumMember 2026-09-30 0000894556 CITR:CompensationAwardsMember srt:MaximumMember 2026-09-30 0000894556 CITR:CompensationAwardsMember CITR:FirstCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:SecondCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:ThirdCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:FourthCapitalizationMember 2025-01-01 2025-12-31 0000894556 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2026-01-01 2026-09-30 0000894556 us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-09-30 0000894556 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-09-30 0000894556 us-gaap:MeasurementInputExpectedDividendRateMember 2026-01-01 2026-09-30 0000894556 us-gaap:WarrantMember 2025-12-31 0000894556 us-gaap:WarrantMember 2025-01-01 2025-12-31 0000894556 us-gaap:WarrantMember 2026-01-01 2026-09-30 0000894556 CITR:ProductsSaleMember 2026-07-01 2026-09-30 0000894556 CITR:ProductsSaleMember 2025-07-01 2025-09-30 0000894556 CITR:ProductsSaleMember 2026-01-01 2026-09-30 0000894556 CITR:ProductsSaleMember 2025-01-01 2025-09-30 0000894556 CITR:ProductInstallationServiceMember 2026-07-01 2026-09-30 0000894556 CITR:ProductInstallationServiceMember 2025-07-01 2025-09-30 0000894556 CITR:ProductInstallationServiceMember 2026-01-01 2026-09-30 0000894556 CITR:ProductInstallationServiceMember 2025-01-01 2025-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2026-07-01 2026-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2025-07-01 2025-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2026-01-01 2026-09-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-12-31 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CITR:CustomersMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CITR:CustomersMember 2025-01-01 2025-12-31 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-01-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-07-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-07-01 2025-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-01-01 2026-09-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-01-01 2025-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-01-01 2026-09-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-01-01 2025-09-30 0000894556 us-gaap:CorporateAndOtherMember 2026-07-01 2026-09-30 0000894556 us-gaap:CorporateAndOtherMember 2025-07-01 2025-09-30 0000894556 us-gaap:CorporateAndOtherMember 2026-01-01 2026-09-30 0000894556 us-gaap:CorporateAndOtherMember 2025-01-01 2025-09-30 0000894556 us-gaap:CorporateAndOtherMember 2026-09-30 0000894556 us-gaap:CorporateAndOtherMember 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CITR:Integer CITR:Customer

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended: September 30, 2026

 

or

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from ___________ to ___________

 

Commission File Number: 001-42983

 

CitroTech Inc.
(Exact name of registrant as specified in its charter)

 

Wyoming   87-2765150
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

6400 S. Fiddlers Green Cir., Suite 300

Greenwood Village, Colorado

  80111
(Address of principal executive offices)   (Zip Code)

 

(800) 401-4535

(Registrant’s telephone number, including area code)

  

Securities registered pursuant to Section 12(b) of the Act: 
 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   CITR   NYSE American LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes   ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) ☐Yes     ☒ No

 

As of November 10, 2026, 24,958,180 shares of the Company’s common stock were issued and outstanding.

 

 

   

 

 

TABLE OF CONTENTS

 

    Page  
       
PART I - FINANCIAL INFORMATION   3  
         
Item 1. Financial Statements   3  
         
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   31  
         
Item 3. Quantitative and Qualitative Disclosures About Market Risk   44  
         
Item 4. Controls and Procedures   44  
       
PART II - OTHER INFORMATION   45  
       
Item 1. Legal Proceedings   45  
         
Item 1A. Risk Factors   45  
         
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   45  
         
Item 3. Defaults Upon Senior Securities   45  
         
Item 4. Mine Safety Disclosures   45  
         
Item 5. Other Information   45  
         
Item 6. Exhibits   46  
         
SIGNATURES   47  

 

 

 

 2 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Index to Unaudited Interim Consolidated Financial Statements

September 30, 2026

 

 

Contents   Page  
       
Consolidated Balance Sheets at September 30, 2026 and December 31, 2025   4  
       
Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2026 and 2025   5  
       
Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2026 and 2025   6  
       
Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025   8  
       
Notes to Unaudited Interim Consolidated Financial Statements   9  


 

 

 

 

 

 

 

 

 

 3 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Balance Sheets

(Unaudited)

         
   September 30,   December 31, 
   2026   2025 
Assets        
Current Assets          
Cash  $1,088,701   $6,268,591 
Accounts receivable, net   263,751    209,047 
Inventory   542,280    620,768 
Prepaid expenses   313,740    317,020 
Deferred offering costs   134,295    – 
Total Current Assets   2,342,767    7,415,426 
           
Non-Current Assets          
Intangible assets, net   5,040,565    5,326,960 
Operating lease right-of-use asset   636,055    753,363 
Equipment, net   469,495    630,279 
Security deposit   57,491    57,491 
Total Non-Current Assets   6,203,606    6,768,093 
           
Total Assets  $8,546,373   $14,183,519 
           
Liabilities and Stockholders' Equity          
Current liabilities          
Accounts payable and accrued liabilities  $589,605   $316,321 
Deferred revenue   12,466    3,000 
Convertible notes, net of discount   –    219,321 
Convertible notes, net of discount - related parties   –    1,285,400 
Due to related parties   2,700    167,971 
Financing loan - current portion   16,591    30,000 
Operating lease liability - current portion   161,560    147,613 
Total Current Liabilities   782,922    2,169,626 
           
Non-Current Liabilities          
Financing loan   60,591    133,381 
Operating lease liability   494,396    617,598 
Total Non-Current Liabilities   554,987    750,979 
           
Total Liabilities   1,337,909    2,920,605 
           
Stockholders' Equity          
Preferred Stock, par value $0.0001, authorized 30,000,000 shares:          
Series A Preferred Stock, par value $0.0001, designated 10,000,000 shares, 0 and 1,666,667 shares issued and outstanding, respectively   –    167 
Series C Convertible Preferred Stock, par value $0.0001, designated 10,000,000 shares, 212,149 and 807,668 shares issued and outstanding, respectively   21    81 
Common Stock, par value $0.0001, authorized 1,000,000,000 shares, 22,718,180 and 18,522,315 issued and outstanding, respectively   2,272    1,852 
Additional paid-in capital   132,802,205    124,463,845 
Accumulated deficit   (125,596,034)   (113,203,031)
Total Stockholders' Equity   7,208,464    11,262,914 
Total Liabilities and Stockholders' Equity  $8,546,373   $14,183,519 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 4 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

                     
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Revenue  $664,328   $288,212   $1,289,909   $1,945,232 
                     
Operating expenses                    
Cost of revenue, exclusive of amortization and depreciation shown separately below   474,535    575,603    1,201,385    1,503,965 
Cost of revenue - related parties   –    –    –    60,290 
Amortization and depreciation   120,820    90,054    370,354    241,700 
General and administrative   278,894    269,703    907,140    743,101 
Advertising and marketing   294,396    232,569    642,788    489,673 
Payroll and management compensation   999,271    2,437,089    5,938,321    5,445,210 
Professional fees   625,651    820,968    1,954,203    1,881,254 
Professional fees - related parties   11,400    20,224    79,060    2,164,824 
Research and development expense   145,919    79,700    424,511    129,008 
Total operating expenses   2,950,886    4,525,910    11,517,762    12,659,025 
                     
Loss from operations   (2,286,558)   (4,237,698)   (10,227,853)   (10,713,793)
                     
Other income (expense)                    
Interest expense   (2,131)   (360,236)   (170,533)   (1,323,112)
Interest expense - related party   –    (980,494)   (804,847)   (1,255,337)
Interest income   8,804    4,423    51,654    8,381 
Financing expense   –    –    –    (6,167,334)
Financing expense - related party   –    –    (361,801)   (2,511,855)
Gain (loss) on fair value of derivative liability   –    1,775,000    –    (2,002,767)
Loss on sales of assets   –    –    (32,257)   – 
Loss on settlement of debt   –    (4,130,203)   (847,366)   (6,770,814)
Total other income (expense)   6,673    (3,691,510)   (2,165,150)   (20,022,838)
                     
Loss before taxes   (2,279,885)   (7,929,208)   (12,393,003)   (30,736,631)
                     
Provision for income taxes   –    –    –    – 
Net loss  $(2,279,885)  $(7,929,208)  $(12,393,003)  $(30,736,631)
                     
Comprehensive loss  $(2,279,885)  $(7,929,208)  $(12,393,003)  $(30,736,631)
                     
Net loss per common share - basic and diluted  $(0.10)  $(0.59)  $(0.59)  $(2.88)
Basic and diluted weighted average number of common shares outstanding   22,175,863    13,521,896    21,073,842    10,673,390 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 5 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the three and nine months ended September 30, 2026

                                              
   Series A   Series C Convertible           Additional       Total 
   Preferred stock   Preferred stock   Common Stock   Paid-In   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
                                     
Balance - December 31, 2025   1,666,667   $167    807,668   $81    18,522,315   $1,852   $124,463,845   $(113,203,031)  $11,262,914 
Common stock issued for conversion of debt   –    –    –    –    171,878    17    1,259,849    –    1,259,866 
Common stock issued for services   –    –    –    –    22,000    2    160,378    –    160,380 
Common stock issued for cashless exercise of warrants   –    –    –    –    180,708    18    (18)   –    – 
Common stock issued for stock payable   –    –    –    –    220,000    22    (22)   –    – 
Management stock compensation   –    –    –    –    –    –    2,116,178    –    2,116,178 
Contributed capital   –    –    –    –    –    –    96,258    –    96,258 
Net loss   –    –    –    –    –    –    –    (6,210,564)   (6,210,564)
Balance - March 31, 2026   1,666,667   $167    807,668   $81    19,116,901   $1,911   $128,096,468   $(119,413,595)  $8,685,032 
Series A Preferred Stock exchanged for Series C Preferred Stock and Series C Preferred Stock payable   (1,666,667)   (167)   103,558    10    –    –    157    –    – 
Common stock issued for conversion of Series C Preferred Stock   –    –    (699,077)   (70)   2,330,273    233    (163)   –    – 
Common stock issued for services   –    –    –    –    33,333    4    282,993    –    282,997 
Common stock issued for conversion of debt   –    –    –    –    940,799    94    2,257,823    –    2,257,917 
Common stock issued for exercise of warrants   –    –    –    –    8,334    1    25,001    –    25,002 
Management stock compensation   –    –    –    –    83,334    8    1,302,659    –    1,302,667 
Warrants issued for services   –    –    –    –    –    –    361,801    –    361,801 
Net loss   –    –    –    –    –    –    –    (3,902,554)   (3,902,554)
Balance - June 30, 2026   –   $–    212,149   $21    22,512,974   $2,251   $132,326,739   $(123,316,149)  $9,012,862 
Common stock issued for cashless exercise of warrants   –    –    –    –    164,706    17    (17)   –    – 
Common stock issued for services   –    –    –    –    3,000    –    16,800    –    16,800 
Management stock compensation   –    –    –    –    37,500    4    393,006    –    393,010 
Warrants issued for services   –    –    –    –    –    –    65,677    –    65,677 
Net loss   –    –    –    –    –    –    –    (2,279,885)   (2,279,885)
Balance - September 30, 2026   –   $–    212,149   $21    22,718,180   $2,272   $132,802,205   $(125,596,034)  $7,208,464 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 6 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the three and nine months ended September 30, 2025

                             
   Series A   Series C Convertible           Additional       Total 
   Preferred stock   Preferred stock   Common Stock   Paid-In   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
                                     
Balance - December 31, 2024   1,666,667   $167    3,001,969   $300    6,140,264   $614   $79,680,114   $(76,365,388)  $3,315,807 
Series C Preferred Stock issued for cash   –    –    27,500    3    –    –    259,997    –    260,000 
Series C Preferred Stock issued for services   –    –    167,500    17    –    –    2,349,003    –    2,349,020 
Series C Preferred Stock issued for compensation   –    –    30,000    3    –    –    420,717    –    420,720 
Common stock issued for conversion of Series C Preferred Stock   –    –    (776,831)   (78)   2,589,450    259    (181)   –    – 
Common stock warrants issued   –    –    –    –    –    –    8,649,503    –    8,649,503 
Net loss   –    –    –    –    –    –    –    (10,903,404)   (10,903,404)
Balance - March 31, 2025   1,666,667   $167    2,450,138   $245    8,729,714   $873    91,359,153   $(87,268,792)  $4,091,646 
Series C Preferred Stock issued for services   –    –    69,007    7    –    –    2,511,848    –    2,511,855 
Series C Preferred Stock issued for compensation   –    –    50,000    5    –    –    1,099,995    –    1,100,000 
Common stock issued for conversion of Series C Preferred Stock   –    –    (532,638)   (53)   1,775,466    178    (125)   –    – 
Common stock issued for services   –    –    –    –    1,667    –    19,000    –    19,000 
Common stock issued for conversion of debts   –    –    –    –    507,661    50    5,604,392    –    5,604,442 
Management stock compensation   –    –    –    –    –    –    767,669    –    767,669 
Net loss   –    –    –    –    –    –    –    (11,904,019)   (11,904,019)
Balance - June 30, 2025   1,666,667   $167    2,036,507   $204    11,014,508   $1,101   $101,361,932   $(99,172,811)  $2,190,593 
Series C Preferred Stock issued for cash   –    –    420,943    42    –    –    5,395,755    –    5,395,797 
Series C Preferred Stock issued for services   –    –    5,000    –    –    –    98,167    –    98,167 
Series C Preferred Stock issued for compensation   –    –    6,250    1    –    –    117,916    –    117,917 
Common stock issued for conversion of debt   –    –    –    –    818,709    82    5,124,232    –    5,124,314 
Common stock issued for conversion of Series C Preferred Stock   –    –    (1,705,000)   (171)   5,683,336    568    (397)   –    – 
Common stock issued for services   –    –    –    –    36,000    4    215,636    –    215,640 
Management stock compensation   –    –    –    –    150,000    15    1,692,447    –    1,692,462 
Reclassification of derivative liability to equity   –    –    –    –    –    –    1,604,000    –    1,604,000 
Reverse stock split adjustment   –    –    –    –    359    –    –    –    – 
Net loss   –    –    –    –    –    –    –    (7,929,208)   (7,929,208)
Balance - September 30, 2025   1,666,667   $167    763,700   $76    17,702,912   $1,770   $115,609,688   $(107,102,019)  $8,509,682 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 7 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Cash Flows

(Unaudited)

 

           
   Nine months ended 
   September 30, 
   2026   2025 
Cash Flows from Operating Activities:          
Net loss  $(12,393,003)  $(30,736,631)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   4,337,709    10,844,329 
Stock-based compensation - related party   361,801    4,615,455 
Bad debt expense recovery   (20,000)   – 
Non-cash lease expenses   117,308    123,334 
Amortization and depreciation   370,354    241,700 
Amortization of debt discount   155,679    1,131,734 
Amortization of debt discount - related party   736,600    1,094,944 
Loss on settlement of debt   847,366    6,770,814 
Loss on fair value of derivative liability   –    2,002,767 
Loss on disposal of equipment   32,257    – 
Write off of deferred offering costs   –    197,415 
Changes in operating assets and liabilities:          
Accounts receivable   (34,704)   (190,720)
Inventory   78,488    (237,957)
Prepaid expenses   3,280    (12,939)
Security deposit   –    (36,991)
Accounts payable and accrued liabilities   192,614    730,756 
Due to related parties   2,400    25,300 
Accrued interest - related parties   68,247    160,393 
Deferred revenue   9,466    6,000 
Operating lease liabilities   (109,255)   (116,135)
Net Cash used in Operating Activities   (5,243,393)   (3,386,432)
           
Cash Flows from Investing Activities:          
Purchase of equipment   (21,527)   (221,670)
Sale of equipment   12,500    – 
Net Cash used in Investing Activities   (9,027)   (221,670)
           
Cash Flows from Financing Activities:          
Proceeds from exercise of warrants   25,002    – 
Proceeds from convertible notes and warrants   –    1,909,000 
Proceeds from convertible note and warrants - related party   –    1,776,082 
Payments of deferred offering costs   (15,205)   (71,311)
Contributed capital   96,258    – 
Repayment of loan - related party   –    (25,000)
Proceeds from issuance of Series C Preferred Stock and warrants   –    5,655,797 
Repayment of financing loan   (33,525)   (215,625)
Net Cash provided by Financing Activities   72,530    9,028,943 
           
Change in cash   (5,179,890)   5,420,841 
Cash, beginning of period   6,268,591    775,133 
Cash, end of period  $1,088,701   $6,195,974 
           
Supplemental Disclosure Information:          
Cash paid for interest  $10,128   $5,913 
Cash paid for taxes  $–   $– 
           
Non-Cash Financing Disclosure:          
Series A Preferred Stock exchanged for Series C Preferred Stock and Series C Preferred Stock payable  $157   $– 
Common stock issued upon conversion of Series C Preferred stock  $233   $1,005 
Common stock issued for conversion and settlement of debt  $1,259,866   $10,728,756 
Common stock issued for conversion and settlement of related party debt  $2,257,917   $– 
Common stock issued for cashless exercise of warrants  $35   $– 
Common stock issued for stock payable  $22   $– 
Debt modification  $222,000   $– 
Warrants issued in conjunction with convertible debts  $–   $882,000 
Right-of-use assets obtained in exchange for new operating lease liabilities  $–   $865,218 
Recognition of derivative liability as debt discount  $–   $1,027,000 
Reclassification of derivative liability to additional paid-in capital  $–   $1,604,000 
Transfer from inventory to property and equipment  $–   $74,827 
Acquisition of property and equipment as financing loan  $–   $291,528 
Offering costs in accounts payable  $119,090   $– 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 8 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Notes to Unaudited Interim Consolidated Financial Statements

September 30, 2026

 

Note 1 – Organization, Business and Going Concern

 

CitroTech Inc. was originally incorporated under the laws of the State of Nevada on March 14, 1990 and on June 3, 2021 was redomiciled to the State of Wyoming. Effective on January 22, 2026, the Company changed its name from General Enterprise Ventures, Inc. to CitroTech Inc. When used in these notes, the terms “CITR,” “Company,” “we,” “us” and “our” mean CitroTech Inc. and all entities included in our unaudited interim consolidated financial statements.

 

Business

 

We develop and manufacture environmentally sustainable, non-toxic, long-term fire-inhibiting products for use in industrial and wildfire defense applications. The Company’s proprietary formulation, CitroTech®, is derived from food-grade, renewable materials and is designed to provide an alternative to legacy conventional chemical fire retardants. CitroTech is used in the manufacturing of fire-resilient lumber and building materials, enabling integration of flame-inhibiting properties during production or applied in the field to new homes. In addition, it is utilized by fire departments, municipalities, and other public and private sector entities in connection with ground-based wildfire defense and stationary application systems intended to help render vegetation non-flammable, reduce ignition risk and enhance structural protection.

 

The Company continues to evaluate and develop additional formulations and product treatments to expand the range of potential commercial applications for its technology.

  

Liquidity and Going Concern

 

The accompanying unaudited interim consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.

 

At September 30, 2026, the Company had cash of approximately $1.1 million, working capital of $1.6 million, and an accumulated deficit of $125.6 million. For the nine months ended September 30, 2026, the Company incurred a net loss of $12.4 million and used approximately $5.2 million of cash in operating activities. In October 2026, the Company received net proceeds of approximately $5.2 million from equity financing (see Note 14). The Company's ability to continue as a going concern depends on its ability to scale commercial sales. Management believes that current cash including the net proceeds from the October 2026 financing is not sufficient to fund commercial-scale production and the related working capital requirements for the next twelve months. These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year following the issuance date of these unaudited interim consolidated financial statements.

 

To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity or debt securities. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

 

 

 9 

 

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

Our unaudited interim consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of CitroTech Inc. for the year ended December 31, 2025.

 

In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of September 30, 2026 and its results of operations for the three and nine months ended September 30, 2026 and 2025, and cash flows for the nine months ended September 30, 2026 and 2025. The balance sheet at December 31, 2025, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

 

The accompanying unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended December 31, 2025, as filed with the SEC on March 30, 2026.

  

Principles of Consolidation

 

The consolidated financial statements include the accounts of CitroTech Inc., and its wholly owned subsidiaries. Intercompany transactions and balances have been eliminated.

 

Reclassification

 

Certain amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact on previously reported total assets, liabilities, equity, net income (loss), or cash flows for any periods presented.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

 

Cash and Cash Equivalents

 

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company did not have any cash equivalents at September 30, 2026 and December 31, 2025. The Company had cash of $1.1 million and $6.3 million at September 30, 2026 and December 31, 2025, respectively.

 

 

 

 10 

 

 

Periodically, the Company may carry cash balances at financial institutions in excess of federally insured limit of $250,000 per institution. The amount in excess of the FDIC insurance as of September 30, 2026, was approximately $487,000. The Company has not experienced losses on account balances and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.

 

Accounts Receivable

 

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any expected loss on the trade accounts receivable balances and charged to the provision for credit loss. The Company maintains allowances for credit loss for estimated losses resulting from the inability of its customers to make the required payments for products and services. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered.

  

During the nine months ended September 30, 2026, the Company recovered $20,000 of previously reserved accounts receivable. Accordingly, the Company reversed the related allowance for credit losses, which was recorded as a reduction of general and administrative expenses. As of September 30, 2026, the Company determined that the remaining reserved accounts receivable balance was uncollectible and wrote it off against the existing allowance for credit losses. The allowance for credit losses was $0 and $340,950 as of September 30, 2026 and December 31, 2025, respectively.

 

Fair Value of Financial Instruments

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;
   
  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and
   
  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

Financial instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires the Company to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts recorded, may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.

  

The Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable and accrued liabilities, deferred revenue and loans payable, are carried at historical cost. As of September 30, 2026 and December 31, 2025, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.

 

 

 

 11 

 

 

Convertible Notes

 

The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

Deferred Offering Costs

 

Costs directly attributable to an offering of equity securities are deferred and would be charged against the gross proceeds of the offering as a reduction of additional paid-in capital. Deferred offering costs consist of underwriting, legal, accounting, and other expenses incurred through the balance sheet date that are directly related to the proposed public offering. Should the proposed public offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be expensed. As of September 30, 2026, the Company recorded deferred offering costs of $134,295 related to the S-1 filed in September 2026.

 

Related Parties

 

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

 

Revenue

 

The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

 

Revenue related to contracts with customers is evaluated utilizing the following steps:

 

  i. Identify the contract, or contracts, with a customer;
  ii. Identify the performance obligations in the contract;
  iii. Determine the transaction price;
  iv. Allocate the transaction price to the performance obligations in the contract;
  v. Recognize revenue when the Company satisfies a performance obligation.

 

For the nine months ended September 30, 2026, the Company’s revenue was generated mainly from sales of two fire-retardant products. The first is applied to vegetation for wildfire prevention and asset protection, and is also used in exterior home-protection systems installed on residential properties. The second is used to treat lumber and engineered wood products so they meet fire-retardant-treated wood standards. Revenue from product sales is recognized at a point in time, when control of the product transfers to the customer.

 

Deferred revenue

 

Deferred revenue consists of advanced payments for our installation service that have not yet been rendered. As of September 30, 2026 and December 31, 2025, total deferred revenue was $12,466 and $3,000, respectively. Deferred revenue is expected to be recognized as revenue within the fourth quarter of 2026.

 

 

 

 12 

 

 

Cost of Revenue

 

For the three and nine months ended September 30, 2026 and 2025, cost of revenue consisted of:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Cost of inventory  $415,091   $494,144   $1,017,584   $1,315,378 
Freight and shipping   6,376    15,665    14,466    21,724 
Consulting and advisory-related party   –    –    –    4,000 
Royalty and sales commission-related party   –    –    –    56,290 
Rent expense   53,068    65,794    169,335    166,863 
Total cost of revenue  $474,535   $575,603   $1,201,385   $1,564,255 

 

Basic and Diluted Net Loss Per Common Share

 

Net loss per share of common stock requires presentation of basic and diluted earnings per common share on the face of the Statements of Operations for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share computation to diluted earnings per share. In the accompanying financial statements, basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements and warrants unless the result would be antidilutive.

 

The dilutive effect of share-based payment awards is calculated using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive effect of convertible securities is calculated using the “if-converted method.” Under the if-converted method, securities are assumed to be converted at the beginning of the period, and the resulting shares of common stock are included in the denominator of the diluted calculation for the entire period being presented.

 

As of September 30, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

          
   September 30,   September 30, 
   2026   2025 
   Shares   Shares 
Convertible notes   –    1,266,987 
Common Stock warrants   2,612,974    1,925,768 
Series C Convertible Preferred Stock   707,163    2,545,667 
Series C Convertible Preferred Stock to be issued   2,490,040    – 
Performance stock units   1,383,333    2,016,667 
Restricted stock units   412,500    150,000 
    7,606,010    7,905,089 

 

 

 

 13 

 

 

Stock-Based Compensation

 

The Company accounts for employee and non-employee stock awards under ASC 718, Compensation – Stock Compensation, whereby equity instruments issued to employees for services are recorded based on the fair value of the instrument issued and those issued to nonemployees are recorded based on the fair value of the consideration received or the fair value of the equity instrument, whichever is more reliably measurable. Equity grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service.

 

During the three and nine months ended September 30, 2026 and 2025, stock-based compensation was recognized as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Management compensation  $393,010   $1,810,379   $3,811,855   $4,098,768 
Professional fees   82,477    313,807    525,854    578,227 
Professional fees - related party   –    –    –    2,103,600 
Financing expense   –    –    –    6,167,334 
Financing expense - related party   –    –    361,801    2,511,855 
Stock-based compensation  $475,487   $2,124,186   $4,699,510   $15,459,784 

 

Compensation cost for stock awards, which include common shares, Series C Convertible Preferred Stock, warrants and performance stock units (“PSUs”), is measured at the fair value on the grant date and recognized as expense, net of estimated forfeitures, over the related service or performance period. The fair value of stock awards is based on the quoted price of our common stock on the grant date and Series C Convertible Preferred stock as if converted to common stock. We measure the fair value of PSUs using a Monte Carlo valuation model and warrants using a Black-Scholes valuation model. Compensation cost for PSUs is recognized using the derived service period and accelerated if the condition is satisfied at an earlier date.

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of this standard on our disclosures.

 

In September 2025, the FASB issued ASU No. 2025-06, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40).” ASU 2025-06 modernizes the guidance for accounting for internal-use software costs by removing references to project stages and clarifying the threshold applied to begin capitalizing costs. The guidance in ASU 2025-06 is effective for fiscal years beginning after December 15, 2027 and interim periods within those fiscal years, and can be applied prospectively, retrospectively, or using a modified transition approach. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2025-06 on the Company’s consolidated financial statements and related disclosures.

 

 

 

 14 

 

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11.

 

In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective annual periods beginning after December 15, 2026, and interim periods within those years. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Recently adopted accounting pronouncement

 

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years. The Company adopted ASU 2025-05, as of January 1, 2026, and applied the new disclosure requirements prospectively to the current annual period. The adoption of this ASU did not have an impact on our consolidated financial statements.

 

Note 3 – Inventory

 

As of September 30, 2026 and December 31, 2025, inventory consisted of the following: 

          
   September 30,   December 31, 
   2026   2025 
Finished goods  $101,187   $185,310 
Raw materials   441,093    435,458 
Inventory  $542,280   $620,768 

 

The Company did not write-off any inventories as unsalable for the nine months ended September 30, 2026 and 2025.

 

 

 

 

 15 

 

 

Note 4 – Prepaid Expenses

 

As of September 30, 2026 and December 31, 2025, prepaid expenses, consisted of the following: 

          
   September 30,   December 31, 
   2026   2025 
Insurance  $51,176   $180,970 
Legal retainer   5,000    – 
Research and development   124,902    – 
Advertising and marketing   40,962    18,345 
Other prepaid operating expenses   78,309    94,705 
Deposit on purchase of inventories   13,391    23,000 
Prepaid expenses  $313,740   $317,020 

 

Note 5 – Equipment, net

 

As of September 30, 2026 and December 31, 2025, equipment consisted of the following:

          
   September 30,   December 31, 
   2026   2025 
Cost:          
Equipment  $52,625   $43,396 
Vehicles   574,069    686,434 
Software under development   10,800    – 
Equipment gross   637,494    729,830 
Less: accumulated depreciation   (167,999)   (99,551)
Equipment, net  $469,495   $630,279 


As of September 30, 2026, Software under development represents capitalized costs related to the development of a mobile application system. The system is currently under development and has not been placed in service.

 

During the three and nine months ended September 30, 2026 and 2025, the Company recorded depreciation as follows.

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Depreciation  $25,355   $28,071   $83,959   $55,751 

 

 

 

 16 

 

 

During the nine months ended September 30, 2026, the Company purchased equipment for $10,727. During the nine months ended September 30, 2025, the Company purchased vehicles and equipment for $588,025, of which $291,528 were purchased with a financing loan, and transferred vehicles from inventory of $74,827 due to a change of use in 2025.

 

During the nine months ended September 30, 2026, the Company sold and disposed of vehicles and equipment with a net book value of $98,353. In connection with these dispositions, the Company received cash from sale of equipment of $12,500, settled the related finance loan of $67,725 and paid $15,051 for settlement of finance loan, and settled other current liability of $922, resulting in a loss on disposal of $32,257.

 

Financing loan

 

The Company had a financing loan for the purchase of a vehicle in September 2025. The loan repayment is $2,021 per month for 60 months, beginning October 2025, with an interest rate of 11.33%.

 

The Company had a financing loan for the purchase of a vehicle in September 2025. The loan repayment is $2,083 per month for 48 months, beginning October 2025, with an interest rate of 11.90%. In June 2026, the Company sold the vehicle with a net book value of $83,489 and paid $15,051 to settle financing loan of $67,725. As a result, the Company recorded loss on disposal of $30,815.

 

During the three and nine months ended September 30, 2026 and 2025, the Company recorded interest expense as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Interest expense  $2,131   $22   $10,128   $4,973 

 

As of September 30, 2026 and December 31, 2025, the Company had a financing loan of $77,182 and $163,381, respectively.

 

Note 6 – Intangible Assets, net

 

In 2022, the Company acquired the intellectual property of Mighty Fire Breaker LLC (“MFB California”), 19 patents centered around its MFB Technology for the prevention of the spread of wildfires. The granted patents include MFB California’s main chemistry and applications. MFB California had 21 trademarks and various copyrights. Internally generated patents, trademarks and copyrights, are expensed as incurred.

 

In December 2025, the Company entered into an Intellectual Property Purchase Agreement to protect our existing patents. The purchase price is $100,000 in cash and 220,000 shares of Common stock valued at $1,775,400, which shall be issued within 30 days of the closing date. The common stock was issued in January 2026.

 

 

 

 

 17 

 

 

As of September 30, 2026 and December 31, 2025, finite-lived intangible assets consisted of the following:

          
   September 30,   December 31, 
   2026   2025 
Acquired patents (19)  $4,195,353   $4,195,353 
Patent and technology assets   1,243,000    1,243,000 
Non-compete agreements   632,400    632,400 
Accumulated amortization   (1,030,188)   (743,793)
Intangible assets, net  $5,040,565   $5,326,960 

 

Estimated future amortization expense for finite-lived intangibles is as follows:

     
Year ending December 31,    
2026 (remaining three months)  $95,492 
2027   381,888 
2028   381,888 
2029   381,888 
2030   381,888 
Thereafter   3,417,521 
Intangible assets, net  $5,040,565 

 

As of September 30, 2026, the weighted-average useful life is 13.34 years.

 

During the three and nine months ended September 30, 2026 and 2025, the amortization expense was as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Amortization  $95,465   $61,983   $286,395   $185,949 

 

Note 7 – Lease

 

In March 2022, the Company entered into an operating lease for a warehouse, with a term of eighteen (18) months. In July 2023, the Company amended the contract and extended the lease term to July 2025. In May 2025, the Company terminated this lease and wrote off the right-of-use asset and lease liability.

 

In January 2025, the Company entered into an operating lease for our office and warehouse. The commencement date was April 1, 2025, and the termination date is March 31, 2030. The Company recorded a security deposit of $36,991. 

 

 

 

 18 

 

 

For the three and nine months ended September 30, 2026 and 2025, the components of lease expense were as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
The components of lease expense were as follows:                
Operating lease cost  $51,380   $51,379   $154,138   $138,688 
Short-term lease cost   2,990    11,307    22,531    53,272 
Variable lease cost   9,302    17,320    28,799    30,524 
Total lease cost  $63,672   $80,006   $205,468   $222,484 

 

Supplemental cash flow information related to leases was as follows:

          
   Nine months ended 
   September 30, 
   2026   2025 
Cash paid for operating cash flows from operating leases  $146,084   $163,194 
Right-of-use asset obtained in exchange for new operating lease liabilities  $–   $865,218 
           
Weighted-average remaining lease term - operating leases (year)   3.50    4.50 
Weighted-average discount rate — operating leases   7.00%    7.00% 

 

The following table outlines maturities of our lease liabilities as of September 30, 2026:

     
Year ending December 31,    
2026 (remaining three months)  $49,327 
2027   203,228 
2028   211,357 
2029   219,812 
2030   55,486 
Thereafter   – 
Operating leases, future minimum payments due   739,210 
Less: Imputed interest   (83,254)
Operating lease liabilities  $655,956 

 

 

 

 

 19 

 

 

Note 8 – Convertible Notes

 

The components of convertible notes as of September 30, 2026 and December 31, 2025, were as follows:

                        
   Principal      Effective
Interest
  Stated
Interest
  September 30,   December 31, 
Payment date  Amount   Maturity date  Rate  Rate  2026   2025 
February 15, 2025  $575,000   February 15, 2026  510%  10%  $          –   $375,000 
Total Convertible notes                 –    375,000 
Less: Unamortized debt discount                 –    (155,679)
                  –    219,321 
Less: Current portion                 –    (219,321)
Long-term portion                $–   $– 

 

During the three and nine months ended September 30, 2026 and 2025, the Company recognized interest expense and amortization of debt discount as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Interest expense  $–   $49,474   $4,726   $186,405 
Amortization of debt discount  $–   $310,740   $155,679   $1,131,734 

 

As of September 30, 2026 and December 31, 2025, the Company recorded accrued interest of $0 and $32,773, respectively.

  

Conversion

 

In February 2026, seven (7) note holders converted convertible notes issued in February 2025 of $375,000 and accrued interest of $37,500 into 171,878 shares of common stock with a conversion price of $2.40. As a result, the Company settled convertible notes and accrued interest of $412,500, and recorded loss on settlement of debt of $847,366.

 

Note 9 – Accounts Payable and Accrued Liabilities

 

As of September 30, 2026 and December 31, 2025, accounts payable and accrued liabilities consisted of the following:

          
   September 30,   December 31, 
   2026   2025 
Accounts payable  $439,616   $169,278 
Accrued interest   –    32,773 
Credit card   7,666    19,953 
Sales tax payable   15,965    27,675 
Other liabilities   –    53,280 
Payroll liability   126,358    13,362 
Accounts payable and accrued liabilities  $589,605   $316,321 

 

 

 

 20 

 

 

Note 10 – Related Party Transactions

 

The related parties that had material transactions for the nine months ended September 30, 2026 and 2025, consist of the following:

 

Related Party   Nature of Relationship to the Company
A   An Ohio Corporation - a significant shareholder
B   Owner of A and our Chairman of the Board
C   A California Corporation owned by a related party D
D   Significant shareholder and our Chief Technology Officer through March 31, 2026
E   Former Director and Chief Executive Officer of GEVI Insurance Holdings Inc.
F   A Delaware limited liability company controlled by a Director and significant shareholder
G   A company controlled by our Chief Financial Officer

 

As of September 30, 2026 and December 31, 2025, amounts owing to related parties consisted of:

             
   September 30,   December 31,    
Related Party  2026   2025   Nature of transaction
A  $–   $300   Payment of operating expenses on behalf of the Company
F   –    167,671   Accrued interest related to convertible note related party
G   2,700    –   Consulting fees
   $2,700   $167,971    

 

During the nine months ended September 30, 2026, the Company repaid $300 to related party A.

 

As of September 30, 2026, deferred offering costs included $4,050 in consulting fees to related party G, for services in connection with the Company's Form S-1 registration statement.

 

For the three and nine months ended September 30, 2026 and 2025, expenses to related parties and their nature consisted of:

 

   Three months ended       
   September 30,       
Related Party  2026   2025   Nature of transaction  Financial Statement Line Item
G  $–   $1,458   Edgar filing expense  General and administrative
G  $11,400   $20,224   Professional service - accounting  Professional fees - related party

  

 

 

 

 21 

 

 

   Nine months ended       
   September 30,       
Related Party  2026   2025   Nature of transaction  Financial Statement Line Item
A  $–   $2,103,600   150,000 Series C preferred stock for consulting fee  Professional fees - related party
A  $–   $25,300   Payment of operating expenses on behalf of the Company  Operating expenses
A  $–   $25,000   Repayment of loan  Due to related party
C  $–   $21,600   Cash paid for consulting fees  Professional fees - related party
C  $–   $4,000   Cash paid for consulting and advisory fees  Cost of revenue - related party
D  $–   $56,290   Cash paid for royalty and sales commissions  Cost of revenue - related party
D  $30,000   $–   Cash paid for consulting fees  Professional fees - related party
E  $–   $420,720   30,000 Series C preferred stock for management compensation  Management compensation
F  $–   $2,511,855   69,007 Series C preferred stock for services  Financing expense
G  $5,505   $16,065   EDGAR filing expense  General and administrative
G  $49,060   $39,624   Professional service - accounting  Professional fees - related party

 

Contributed Capital

 

In February 2026, the Company received payments from related party B, totaling $96,258 related to disgorgement of short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Company recognized these proceeds as a capital contribution and the amounts were recorded as an increase to additional paid-in capital on the unaudited interim consolidated balance sheets.

 

Convertible note – related party

 

The components of convertible notes as of September 30, 2026 and December 31, 2025, were as follows:

                        
          Effective  Stated        
   Principal      Interest  Interest  September 30,   December 31, 
Payment date  Amount   Maturity date  Rate  Rate  2026   2025 
February 2025  $2,222,000   April 28, 2026  16.25%  10%  $        –   $2,000,000 
Total Convertible notes                $–   $2,000,000 
Less: Unamortized debt discount                 –    (714,600)
                  –    1,285,400 
Less: Current portion                 –    (1,285,400)
Long-term portion                $–   $– 

 

In February 2025, the Company entered into one (1) subscription agreement for convertible note ($2,000,000) and warrants (416,667 shares of common stock) with related party F. The convertible note has a term of twelve (12) months, at an interest rate of 10% per annum and warrants are with a term of five (5) years, at exercise price of $3.00 per share. The outstanding principal amount of convertible note and unpaid interest is convertible at a fixed conversion price of $2.40. The obligations of the Company under the convertible note are secured by a pledge of the Company’s membership interests in MFB Ohio. In the event of a default, related party F could proceed against the equity of MFB Ohio pledged to collateralize the convertible note. MFB Ohio owns the Company’s intellectual property portfolio. On February 27, 2026, related party F extended their convertible promissory note until April 28, 2026. Pursuant to the extension, they charged a 1% amendment fee and agreed to release their security pledge against certain intangible assets of the Company. As a result, the principal amount became $2,222,000, including accrued interest of $200,000 and 1% fee of $22,000.

 

 

 

 22 

 

 

The Company evaluated the modification of terms under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the extension of the maturity dates did not result in a substantial change to the economic substance of the debt and thus resulted in a modification of the debt and not extinguishment of the debt. Accordingly, no gain or loss on debt extinguishment was recorded.

 

During the three and nine months ended September 30, 2026 and 2025, the Company recognized interest expense and amortization of debt discount as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Interest expense - related party  $–   $64,946   $68,247   $160,393 
Amortization of debt discount - related party  $–   $915,548   $736,600   $1,094,944 

 

Conversion

 

In April 2026, related party F converted a convertible note with principal of $2,222,000 and accrued interest of $35,917 into 940,799 shares of common stock with a conversion price of $2.40.

 

As of September 30, 2026 and December 31, 2025, the Company recorded accrued interest of $0 and $167,671, respectively.

 

Note 11 – Stockholders’ Equity

 

Preferred Stock

  

The Company is authorized to issue up to 30,000,000 shares of Preferred Stock, par value $0.0001 per share.

 

Series A Preferred Stock

 

The Company designated 10,000,000 shares of its Preferred Stock as Series A Preferred Stock, par value $0.0001, with the following rights and privileges.

 

Dividends. Holders of shares of Series A Preferred Stock are not entitled to receive dividends.

 

Voting Rights. Each share of Series A Preferred Stock is entitled to 1,000 votes on all matters submitted to a vote of the holders of Common Stock, voting together with the holders of Common Stock as a single class. Holders of shares of Series A Preferred Stock do not have cumulative voting rights.

 

Other Rights. Shares of Series A Preferred Stock are not entitled to a liquidation preference. The Series A Preferred Stock may not be redeemed without the consent of the holders of the Series A Preferred Stock. The holders of the Series A Preferred Stock are not entitled to pre-emptive rights or subscription rights.

 

 

 

 23 

 

 

Share exchange

 

On May 28, 2026, the Company entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock. Pursuant to the Exchange Agreements, the Company reacquired an aggregate of 1,666,667 shares of Series A Preferred Stock. At closing, the Company issued 103,558 shares of Series C Convertible Preferred Stock to BoltRock Holdings, LLC (“BRH”), and agreed to issue 467,012 shares of Series C Preferred Stock to TC Special Investments LLC (“TCSI”) on the date that is 18 months after closing, unless issued earlier in connection with a change of control of the Company which, under the TCSI Exchange Agreement, includes the appointment of Theodore Ralston to the Company’s board of directors (collectively, the “Exchange Shares”). As a result, the Company recorded the 103,558 shares of Series C Preferred Stock issued to BRH, and the Series C Preferred Stock payable representing the 467,012 shares to be issued to TCSI, as additional paid-in capital.

 

As of September 30, 2026 and December 31, 2025, there were 0 and 1,666,667, respectively, shares of Series A Preferred stock issued and outstanding.

 

Series C Convertible Preferred Stock

 

The Company has designated 10,000,000 shares of its Preferred Stock as Series C Convertible Preferred Stock with the following rights and privileges.

 

Dividends. Holders of shares of Series C Convertible Preferred Stock are not entitled to receive dividends.

 

Voting Rights. The holders of the Series C Convertible Preferred Stock are not entitled to vote.

 

Conversion Rights. Each share of Series C Convertible Preferred Stock outstanding shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into 3.3333 shares of the Common Stock of the Company (the “Conversion Ratio”). Such Conversion Ratio, and the rate at which shares of Series C Convertible Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment.

 

Other Rights. The holders of the Series C Convertible Preferred Stock are not entitled to a liquidation preference. The Series C Convertible Preferred Stock may not be redeemed without the consent of the holders of the Series C Convertible Preferred Stock. The holders of the Series C Convertible Preferred Stock are not entitled to pre-emptive rights or subscription rights.

  

During the nine months ended September 30, 2026, the Company issued 103,558 shares of Series C Convertible Preferred Stock to BRH and 467,012 shares to be issued to TCSI.

 

During the nine months ended September 30, 2025, the Company issued 776,200 shares of Series C Convertible Preferred Stock as follows:

 

·In September 2025, the Company entered into Securities Purchase Agreements with certain investors for the issuance and sale (the “PIPE Offering”) of (i) 420,943 shares of its Series C Convertible Preferred Stock for an aggregate purchase price of approximately $5.4 million, net proceeds and (ii) warrants (the “PIPE Warrants”) to purchase up to 701,563 shares of Common Stock at an offering price of $15.00 per share of Series C Preferred Stock and accompanying PIPE Warrant. The PIPE Warrants are exercisable immediately upon issuance at an exercise price of $6.00 per share and will expire five years from the date of issuance.
·27,500 shares for purchase subscriptions of $260,000, at prices of $4.00 or $6.00 per share
·241,507 shares for services, valued at $4,959,042 at market price on issuance dates.
·86,250 shares for compensation, valued at $1,638,637 at market price on issuance dates.

 

 

 

 24 

 

 

During the nine months ended September 30, 2026, the holders of the Series C Convertible Preferred Stock converted 699,077 shares of the Company’s Series C Convertible Preferred Stock into 2,330,273 shares of the Company’s common stock.

 

As of September 30, 2026 and December 31, 2025, there were 212,149 and 807,668 shares of the Company’s Series C Convertible Preferred Stock issued and outstanding, and 467,012 and 0 shares to be issued, respectively.

 

Common Stock

 

The Company has authorized 1,000,000,000 shares of common stock with a par value of $0.0001. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

 

During the nine months ended September 30, 2026, the Company issued 4,195,865 shares of Common Stock as follows:

 

·2,330,273 shares for conversion of 699,077 shares of Series C Preferred Stock
·1,112,677 shares for conversion of debt of $3,517,783
·58,333 shares for services, valued at $460,177
·353,748 shares for cash and cashless exercise of warrants, for cash proceeds of $25,002
·220,000 shares for stock payable for acquisition of IP, valued at $1,775,400, which was recorded as additional paid-in capital as of December 31, 2025.
·120,834 shares for management compensation valued at $566,672, of which 37,500 shares were issued to our Chief Operating Officer for vested restricted stock units

 

During the nine months ended September 30, 2025, the Company issued 11,562,648 shares of common stock as follows:

 

·10,048,252 shares for conversion of Series C Preferred Stock.
·1,326,370 shares for conversion of debt of $10,728,756.
·37,667 shares for services, valued at $234,640.
·150,000 shares for management compensation.
·359 shares for reverse stock split adjustment.

 

As of September 30, 2026 and December 31, 2025, there were 22,718,180 and 18,522,315 shares of the Company’s common stock issued and outstanding, respectively.

 

Restricted stock units (RSU)

 

On June 27, 2025 (the “Effective Date”), the Company entered into the employment agreement with our Chief Operating Officer (“COO”), commencing on July 21, 2025. Under this agreement, the Company granted 150,000 restricted shares of the Common Stock as stock bonus. Shares shall vest one-fourth on each anniversary of the Effective Date. The grant date fair value of shares is $1,799,970.

 

On September 22, 2025, the Company entered into the employment agreement with our new Chief Executive Officer (“CEO”), commencing on October 1, 2025 (the “Effective Date”). Under this agreement, the Company issued 300,000 restricted shares of the Common Stock as stock bonus. Shares shall vest one-fourth on the first anniversary of the Effective Date and the remaining three-fourths on a monthly basis over the following 36 months. The grant date fair value of shares is $1,698,000.

 

 

 

 25 

 

 

During the three and nine months ended September 30, 2026 and 2025, the Company recognized compensation as follows:

                
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Compensation expense  $218,623   $112,498   $655,869   $112,498 

 

As of September 30, 2026, unrecognized compensation cost for unvested equity awards was $2,510,979, which is expected to be recognized over a remaining weighted-average period of 2.86 years.

 

Management stock compensation (PSU)

 

During 2025, the Company entered into employment and consulting agreements with our CEO, former CEO, COO and a Director. The stock compensation based on market capitalization condition is as follows:

 

Market

capitalization for

30 consecutive days

 

Consulting agreement

Former CEO and Chairman

 

Consulting agreement

Chairman

 

Employment

agreement COO

 

Employment

agreement CEO

$ 120,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   –   –
$ 150,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 200,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 250,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 300,000,000   –   –   37,500 common stock   75,000 common stock
                   
  Fair value ($)   1,932,000   3,165,000   1,740,000   1,580,000
  Forfeiture Protection   Vests upon completion of Initial Term; awards survive termination   Vests upon completion of Initial Term; awards survive termination   Forfeited if terminated for cause or resignation   Forfeited if terminated for cause or resignation

 

The Company used the Monte Carlo model to calculate the fair value of compensation and estimated a total of the grant date fair value of $8,417,000. The Company records compensation expense over the term of a derived service period unless the condition is satisfied at an earlier date.

 

During the three and nine months ended September 30, 2026, the Company recorded compensation expense as follows:

                
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Compensation expense  $174,387   $1,579,965   $2,589,314   $2,347,634 

 

 

 

 26 

 

 

As of September 30, 2026, unrecognized compensation cost for unvested equity awards was $18,284 which is expected to be recognized over a remaining weighted-average period of 0.03 years.

 

As of September 30, 2026, market capitalization performance conditions had been achieved with respect to certain outstanding equity incentive awards. Theodore Ralston, the Company’s former Chief Executive Officer, and BoltRock Holdings, LLC, a company controlled by a Director, each became eligible to receive 140,000 shares of Series C Convertible Preferred Stock, but each has elected to defer receipt of such shares. In addition, Wesley Bolsen, the Company’s Chief Executive Officer, and Andrew Hotsko, the Company’s Chief Operating Officer, became eligible to receive 75,000 and 37,500 shares of common stock, respectively, subject to approval by the Compensation Committee. No shares underlying these awards had been issued as of September 30, 2026.

 

For the year ended December 31, 2025, the estimated fair values of the awards were measured using the following significant assumptions: 

       
Derived service period     0.51 - 1.05 years  
Risk-free interest rate     3.62% - 3.97%  
Stock price at valuation date   $ 5.66 - 12.00  
Expected average volatility     108.5% - 151.0%  
First Capitalization Threshold per share price   $ 6.85 - 14.28  
Second Capitalization Threshold per share price   $ 8.56 - 19.02  
Third Capitalization Threshold per share price   $ 11.42 - 23.82  
Fourth Capitalization Threshold per share price   $ 14.27 - 28.56  

 

Warrants

 

In April 2026, the Company issued 46,250 warrants to a related party F for services. The warrant is for a period of five years at an exercise price per share of $3.00. The Company recorded the value of the warrants of $361,801 to additional paid-in capital.

 

In September 2026, the Company issued 25,000 warrants to a consultant for services. The warrant is for a period of five years at an exercise price per share of $8.00. The Company recorded the warrants value of $65,677 to additional paid-in capital.

 

We evaluate all warrants issued to determine the appropriate classification under ASC 480 and ASC 815. In addition to determining classification, we evaluate these instruments to determine if such instruments meet the definition of a derivative. The classification of all outstanding warrants, including whether such instruments should be recorded as equity, is evaluated at the end of each reporting period.

 

The warrants are valued using a Black Scholes valuation model. The use of this valuation model requires the input of highly subjective assumptions. Any change to these inputs could produce significantly higher or lower fair value measurements.

 

The Company utilized the following assumptions: 

     
   September 30, 
   2026 
Expected term   5.00 years 
Expected average volatility   80 - 89% 
Risk-free interest rate   3.95 - 4.83% 
Expected dividend yield   – 

 

 

 

 27 

 

 

A summary of activity of the warrants during the nine months ended September 30, 2026 is as follows:

               
   Warrants Outstanding     
      

Weighted

Average

Exercise

  

Weighted

Average

Remaining

Contractual life

 
   Shares   Price  

(in years)

 
             
Outstanding, December 31, 2025   2,909,434   $3.66    4.37 
Granted   71,250    4.75    5.00 
Exercised   (367,710)   0.33    – 
Canceled   –    –    – 
Outstanding, September 30, 2026   2,612,974   $4.16    3.68 
                
Exercisable, September 30, 2026   2,446,307   $4.44    3.70 

 

The intrinsic value of the warrants as of September 30, 2026 is approximately $0.5 million.

 

Note 12 – Disaggregated revenue and Concentration

 

During the three and nine months ended September 30, 2026 and 2025, disaggregated revenue was as follows:

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Products sale  $515,628   $91,598   $924,697   $1,142,865 
Product installation service   148,700    196,614    365,212    802,367 
   $664,328   $288,212   $1,289,909   $1,945,232 

 

During the three and nine months ended September 30, 2026 and 2025, customer and supplier concentrations (more than 10%) were as follows:

 

 

 

 28 

 

 

Revenue and accounts receivable

 

Recurring customers do not represent a material percentage of our revenue for the three and nine months ended September 30, 2026 and 2025 and accounts receivable as of September 30, 2026 and December 31, 2025.

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Number of customers (more than 10% revenue)   3    6    –    1 
Total revenue of top 5 customers   58.6%    79.6%    38.8%    37.9% 

 

   September 30,   December 31, 
   2026   2025 
Number of customers (more than 10% of accounts receivable)   1    3 
Total % of accounts receivable balance (more than 10%)   45.6%    61.1% 

 

Purchase and accounts payable for Inventory

                              
   Percentage of Purchases   Percentage of Purchases   Percentage of 
   For three months ended   For nine months ended   Accounts payable for purchase 
   September 30,   September 30,   September 30,   December 31, 
   2026   2025   2026   2025   2026   2025 
Supplier A   –    –    46.8%    32.5%    –    98.8% 
Supplier B   –    –    –    13.6%    –    – 
Supplier C   33.2%    –    19.6%    3.2%    100.0%    – 
Supplier D   8.4%    13.2%    3.0%    19.1%    –    – 
Supplier E   28.2%    17.9%    11.8%    3.3%    –    – 
Supplier F   –    41.9%    –    7.0%    –    – 
Total (as a group)   69.8%    73.0%    81.2%    78.7%    100.0%    98.8% 

 

To reduce risk, the Company closely monitors the amounts due from its customers and assesses the financial strength of its customers through a variety of methods that include, but are not limited to, engaging directly with customer operations and leadership personnel, visiting customer locations to observe operating activities, and assessing customer longevity and reputation in the marketplace. As a result, the Company believes that its accounts receivable credit risk exposure is limited.

 

 

 

 29 

 

 

Note 13 – Segment

 

Our Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reportable segment - environmentally sustainable specialty chemicals for fire prevention and protection in the lumber and wood products, wildland fire and residential home industry.

 

Our CEO assesses performance and decides how to allocate resources primarily based on consolidated loss from operations, which is reported on our Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets.

                    
   Three months ended   Nine months ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Revenue  $664,328   $288,212   $1,289,909   $1,945,232 
                     
Operating expenses                    
Cost of revenue, exclusive of amortization and depreciation shown separately below   474,535    575,603    1,201,385    1,564,255 
Amortization and depreciation   120,820    90,054    370,354    241,700 
General and administrative   278,894    269,703    907,140    743,101 
Advertising and marketing   294,396    232,569    642,788    489,673 
Payroll and management compensation   999,271    2,437,089    5,938,321    5,445,210 
Professional fees   637,051    841,192    2,033,263    4,046,078 
Research and development expense   145,919    79,700    424,511    129,008 
Total operating expenses   2,950,886    4,525,910    11,517,762    12,659,025 
                     
Loss from operations  $(2,286,558)  $(4,237,698)  $(10,227,853)  $(10,713,793)

 

   September 30,   December 31, 
   2026   2025 
Total Assets  $8,546,373   $14,183,519 

 

Note 14 – Subsequent Events

 

Management has evaluated subsequent events through November 10, 2026, which is the date these financial statements were issued. Based on our evaluation, no material events have occurred that require disclosure, except as follows:

 

On October 21, 2026, the Company entered into an underwriting agreement with Univest Securities, LLC, as representative of the underwriters listed on Schedule A thereto in connection with a public offering of 2,240,000 shares of common stock at a public offering price of $2.50 per share. The offering closed on October 22, 2026. The Company received net proceeds of approximately $5.2 million from the offering, after deduction of underwriting discounts and other costs.

 

 

 

 30 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains forward-looking statements. The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results.

 

We caution that the factors described herein, and other factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

Our unaudited financial statements are stated in United States Dollars (USD) and are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this Quarterly Report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this Quarterly Report.

 

In this Quarterly Report, unless otherwise specified, all dollar amounts are expressed in United States Dollars.

 

As used in this Quarterly Report, the terms “we”, “us”, “our” and “our company” mean CitroTech Inc.

 

Overview

 

We are a specialty chemical company focused on environmentally friendly fire inhibitor products serving the wildland fire, residential and commercial property protection, and wood products industries across the United States and Canada. Our fire inhibitor formulations are also used by the lumber and building materials industry for fire retardant treatment applications.

 

The Company’s management team is highly experienced at building and running companies, as well as commercializing and executing on strategic partnerships for the sale of products and services.

 

 

 

 31 

 

 

Since Mighty Fire Breaker LLC (“MFB Ohio”) acquired from Mighty Fire Breaker LLC (“MFB California”) the MFB portfolio of intellectual property on April 13, 2022, our management team has continued to develop and refine our product formulations. The Company has received significant third-party recognition for these efforts, including twice receiving the EPA Safer Choice designation. Our product is the first and only fire inhibitor recognized by the EPA as safe for the environment. We also are the first fire inhibitor to receive UL GREENGUARD Gold certification, which reflects minimal impact on indoor air quality from toxic smoke over extended exposure. Our products have been adopted by fire departments throughout the State of California.

 

CitroTech has 42 granted patents (41 of which are granted in the US) and 90 pending applications (72 of which are pending in the US). We continue to evaluate our patent portfolio and technology platform to target additional markets that can benefit from environmentally safe alternatives to legacy fire retardant and fire retardant-treated wood products. Using this technology, CitroTech has developed products that help achieve Class-A fire rating for lumber and engineered wood products. We are in the initial phases of commercializing this product. In April 2026, CitroTech and Hexion Inc. formed a 50/50 global joint venture named HexiTech LLC, a Delaware limited liability company that will work to commercialize the CitroTech product into factory applied lumber and wood products. This venture is the Company’s primary go-to-market channel for this portion of the business. Large scale ASTM burn tests have been performed as part of the joint venture to be able to bring fact-based data to some of the largest lumber and wood product companies for the potential adoption of CitroTech. The joint venture is working through potential revenues and anticipated adoption timelines for calendar year 2027.

 

The Company is also actively deploying proactive wildfire defense systems on residential and commercial properties under the CitroSafe Systems brand. CitroSafe Systems are self-contained sprinkler installations that utilize our patented CitroTech product. These systems deploy our fire inhibitor in advance of wildfires to help prevent the advance of fires and reduce structural risk. In addition to protecting property owners from the ravages of wildfires, this offering addresses a significant and growing insurance market disruption across the Western United States, where carriers have curtailed or declined to write wildfire coverage on new construction and are cancelling or not renewing existing policies in the Wildland-Urban Interface (“WUI”). WUI is the transitional zone between undeveloped land and built environments that is at elevated risk of catastrophic wildfire loss. The Company is now in discussions with multiple brokers to offer insurance coverage to customers who install a CitroSafe proactive wildfire system, with policies underwritten by established insurance carriers.

 

Our management team consists of four individuals: Wesley J. Bolsen, Chief Executive Officer; Andrew Hotsko, Chief Operating Officer; Nanuk Warman, Secretary and Chief Financial Officer; and Anthony Newton, General Counsel.

 

Known Trends and Uncertainties

 

Growth in Fire Safety

 

We believe that fire safety benefits from several growth drivers, including increasing fire severity, as measured by higher acres burned, longer fire seasons and a growing urban component moving into the WUI, resulting in increased demand for environmentally safe specialty chemical fire inhibitors, thereby increasing production. We believe these trends are prevalent in North America, as well as globally, and we expect these trends to continue driving growth in demand for fire retardants and fire retardant treated lumber products. As of September 30, 2026, our certified partner network consisted of more than 30 organizations that install systems and/or apply CitroTech product around homes and in the community.

 

 

 

 32 

 

 

We are working to grow our fire prevention and protection business, which is primarily focused on expanding use of ground-applications for long-term fire retardants. This growth includes use of ground assets and potentially drones in response to active fires (protection), as well as proactive treatments around critical infrastructure and known high-risk areas (prevention). Fire prevention products can be used to help prevent fire ignitions and protect property from potential fire danger by providing proactive retardant treatment in high-risk areas such as along roadsides, under power lines, along railroad rights-of-way, and around residential neighborhoods and commercial infrastructure. Treating these areas ahead of the fire season can help to prevent ignitions from equipment failures or sparks until a significant rainfall occurs. During 2026, San Diego announced an expansion of its CitroTech treatment program. In addition, certain utilities and railroads began applying CitroTech in pilot applications during Q3 of 2026. Some of these customers have indicated that they are waiting on QPL listing prior to large-scale adoption of the product onto high risk fire threat areas. Although there is no certainty in wildfire defense, when our CitroSafe system is installed, we fill it with our CitroTech product. Thereafter, we will conduct an annual inspection of the system to help ensure it is ready to help defend against a wildfire. While there is no specific useful life for our product, if the system has not been deployed since the third anniversary of the initial installation, or three years following an annual inspection, in an abundance of caution we will recommend the customer replace the CitroTech product. In addition, we suggest spraying CitroTech in areas surrounding the property that pose the greatest risk to help reduce the risk posed by dry vegetation, decks, garden bark, and fences. 

 

We have invested and intend to continue investing in the expansion of our fire retardant and lumber treatment business through product development and business development to grow our customer base.

 

Weather Conditions and Climate Trends

 

Our business is highly dependent on the needs of commercial entities, residential homeowners and fire departments to prevent fires and protect assets, as well as the use and expansion of Class A Fire Retardant Treated lumber and wood products. As such, our financial condition and results of operations are significantly impacted by weather, which impacts the number and severity of fires in any given year. Typically, sales of our product are higher during the summer months in the United States due to weather patterns that are generally correlated to a higher prevalence of wildfires due to drought. We believe orders will generally peak during the late summer months, but with expanded fire seasons in the United States, ignitions may continue through late fall or even into the winter months.

 

In addition, we believe that there are opportunities to apply CitroTech in the future related to prescribed burns to prevent escape from the intended area or re-ignition of a fire after the prescribed burn is concluded. Any such opportunity would depend in part on the CitroTech product being listed on the federal Qualified Products List (“QPL”), which we are pursuing.

 

Results of Operations

 

We are developing and commercializing our product lines. We have been focused historically on obtaining patents and various accreditations. To date, we do not have a large customer base, having relied heavily on a few customers, for the commercialization and testing of our CitroTech product and delivery system. We currently do not have an established retail product line nor recurring significant customer base. 

 

The following summary of our results of operations should be read in conjunction with our unaudited financial statements for nine months ended September 30, 2026 and 2025, which are included herein.

  

 

 33 

 

 

Our results of operations for the three months ended September 30, 2026 and 2025 are summarized below: 

 

   Three Months Ended         
   September 30,         
   2026   2025   Change   % 
Revenue  $664,328   $288,212    376,116    130% 
Operating expenses   2,950,886    4,525,910    (1,575,024)   (35%)
Other income (expense)   6,673    (3,691,510)   3,698,183    (100%)
Net loss  $2,279,885   $7,929,208    (5,649,323)   (71%)

 

Revenue

 

Our revenue is generated through our subsidiary Mighty Fire Breaker LLC ("MFB Ohio"), which acquired our fire suppression intellectual property portfolio in April 2022. Our revenue is highly seasonal and event-driven, with demand concentrated in the Western United States during the traditional May to October fire season, and is materially influenced by wildfire activity in any given period. During the three months ended September 30, 2026, revenue increased $376,000, or 130%, compared to the three months ended September 30, 2025, primarily due to increased sales of products to corporate customers and used in residential installations. In addition, revenue that was booked in the first half of 2025 related to CitroSafe systems is being shifted to our Certified Partners for the installation of systems, with higher margin CitroTech chemical sales that are being put into the system. This accounts for some of the change in revenues from the prior year quarter. No revenues were reported from the HexiTech joint venture during Q3, although some CitroTech product was field applied in the lumber and wood industry during the quarter.

 

Our revenues consisted of the following: 

 

   Three Months Ended 
   September 30, 
   2026   2025 
Products sale  $515,628   $91,598 
Product installation service   148,700    196,614 
   $664,328   $288,212 

 

Our revenues from significant customers for the three months ended September 30, 2026 and 2025, are as follows: 

 

   Three months ended 
   September 30, 
   2026   2025 
Number of customers (more than 10% revenue)   3    6 
Total revenue of top 5 customers   58.6%    79.6% 

 

Our revenue is currently project- and event-driven rather than subscription- or contract-based, and we do not currently have a meaningful base of recurring customers. The decrease in our top-five customer concentration to 58.6% in the three months ended September 30, 2026, from 79.6% in the comparable 2025 period, reflects the shift of system installation revenues to the Certified Partner network while still attracting the higher margin CitroTech chemical sales. We expect customer concentration to remain elevated until our channel partner program and recurring utility and structural-protection customer relationships further mature.

 

 

 

 34 

 

 

Operating Expenses

 

   Three Months Ended         
   September 30,         
   2026   2025   Change   % 
Cost of revenue  $474,535   $575,603    (101,068)   (18%)
Amortization and depreciation   120,820    90,054    30,766    34% 
General and administrative   278,894    269,703    9,191    3% 
Advertising and marketing   294,396    232,569    61,827    27% 
Payroll and management compensation   999,271    2,437,089    (1,437,818)   (59%)
Professional fees   637,051    841,192    (204,141)   (24%)
Research and development expense   145,919    79,700    66,219    83% 
Total operating expenses  $2,950,886   $4,525,910    (1,575,024)   (35%)

 

The decrease in operating expenses was primarily attributed to decreases in management compensation, professional fees, and cost of revenue, partially offset by increases in research and development and marketing costs.

 

Cost of revenue

 

   Three Months Ended         
   September 30,         
   2026   2025   Change   % 
Cost of inventory  $415,091   $494,144    (79,053)   (16%)
Freight and shipping   6,376    15,665    (9,289)   (59%)
Rent expense   53,068    65,794    (12,726)   (19%)
Total cost of revenue  $474,535   $575,603    (101,068)   (18%)

 

During the three months ended September 30, 2026, the cost of revenue decreased over the three months ended September 30, 2025, primarily due to a decrease in cost of inventory.

 

Cost of inventory consists of product costs, direct labor, related supplies, and direct testing of our CitroTech product and the various components required for installation of CitroSafe™ systems. Cost of inventory decreased during the three months ended September 30, 2026, compared to the comparable 2025 period, primarily due to a decrease in outsource labor cost.

 

Freight and shipping relate to costs for shipping products to customers.

 

Rent expenses are warehouse and facility rent expenses.

 

Amortization and depreciation

 

Amortization and depreciation expenses are from the amortization of patents and technology and the depreciation of vehicles, furniture and equipment.

 

 

 

 35 

 

 

General and administrative

 

General and administrative expenses are office, rent, travel, insurance, website, IT, public listing fees, and other office related expenses.

 

Advertising and marketing 

 

The increase in advertising and marketing during the three months ended September 30, 2026, over the three months ended September 30, 2025, is primarily due to supporting revenue growth in addition to investor relations activities after being uplisted to the NYSE American. This includes rebranding efforts around the official company name change to CitroTech Inc. from General Enterprise Ventures Inc as well as the product labels moving from Mighty Fire Breaker to CitroTech and the conversion of relevant website and marketing materials. In addition, during Q3 2026, the Company rang the closing bell of the New York Stock Exchange and engaged in additional Company marketing activities for the benefit of shareholders.

 

Professional fees

 

The professional fees during the three months ended September 30, 2026, includes stock-based compensation of $82,000 to consultants, and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2026. The professional fees during the three months ended September 30, 2025, includes stock-based compensation of $314,000 to consultants and various fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2025.

 

Payroll and management compensation

 

During the three months ended September 30, 2026, payroll and management compensation decreased to $1.0 million from $2.4 million in the prior-year period. This decrease was primarily attributable to lower stock-based compensation. The higher prior-period expense reflected performance stock units (PSUs) granted in 2025 in connection with the buildout of a full executive management team, including the appointment of a Chief Operating Officer, Chief Financial Officer, Chief Technology Officer, and General Counsel. Management compensation for the three months ended September 30, 2026 and 2025 primarily included stock-based management compensation of $0.4 million and $1.8 million, respectively, and payroll to management of $0.4 million in each period. Payroll compensation to employees was approximately $0.3 million as compared to $0.2 million in the prior-year period.

 

Research and development costs


We continue to invest heavily in the testing and certifications of CitroTech treated products as well as submitting formulas for approval to apply product onto federal lands. We are spending on outside testing to ensure that our products can pass the rigorous US Forest Service QPL testing as well as funding additional products to be submitted to the US Forest Service for testing. We expect to continue growing R&D spend over historical spend as we add additional product lines and invest in the future of the company. This includes a funded research program with Texas A&M on new products that were not underway in 2025.

 

Other Income (Expenses)

 

For the three months ended September 30, 2026 and 2025, the other income (expenses) consisted of interest income of $9,000 and $4,000, respectively, interest expense of $2,000 and $1.3 million, respectively, with the 2026 amount related to a finance loan and the 2025 amount primarily related to convertible notes payable issued in 2025 and 2024, change in fair value of derivative liability related to convertible notes payable issued in 2025 and 2024 of $0 and gain of $1.8 million, respectively, and loss on settlement of debt of $0 and $4.1 million, respectively. Settlement of debt in 2025 was the conversion of convertible notes issued in 2025.

  

 

 

 36 

 

 

Net loss

 

The net loss for the three months ended September 30, 2026 was approximately $2.3 million, a decrease of approximately $5.6 million as compared to the three months ended September 30, 2025, primarily due to a significant reduction in other expenses and operating expenses as well as an increase in revenue. 

 

Our results of operations for the nine months ended September 30, 2026 and 2025 are summarized below:

 

   Nine months ended         
   September 30,         
   2026   2025   Change   % 
Revenue  $1,289,909   $1,945,232    (655,323)   (34%)
Operating expenses   11,517,762    12,659,025    (1,141,263)   (9%)
Other expenses   2,165,150    20,022,838    (17,857,688)   (89%)
Net loss  $12,393,003   $30,736,631    (18,343,628)   (60%)

 

Revenue

 

Our revenue is generated through our subsidiary Mighty Fire Breaker LLC ("MFB Ohio"), which acquired our fire suppression intellectual property portfolio in April 2022. Our revenue is highly seasonal and event-driven, with demand concentrated in the Western United States during the traditional May to October fire season, and is materially influenced by wildfire activity in any given period. During the nine months ended September 30, 2026, revenue decreased $0.7 million, or 34%, compared to the nine months ended September 30, 2025. This change was primarily seen in shifts that the Company made in the first quarter of the year, while growing revenue during the third quarter over the prior year.   

 

Our revenues consisted of the following:

 

   Nine months ended 
   September 30, 
   2026   2025 
Products sale  $924,697   $1,142,865 
Product installation service   365,212    802,367 
   $1,289,909   $1,945,232 

 

Our revenues from significant customers for the nine months ended September 30, 2026 and 2025, are as follows: 

 

   Nine months ended 
   September 30, 
   2026   2025 
Number of customers (more than 10% revenue)   –    1 
Total revenue of top 5 customers   38.8%    37.9% 

 

 

 

 37 

 

 

Our revenue is project- and event-driven rather than subscription- or contract-based, and we do not currently have a meaningful base of recurring customers. The increase in our top-five customer concentration to 38.8% in the nine months ended September 30, 2026, from 37.9% in the comparable 2025 period, reflects the early-stage nature of our commercial customer base. We expect customer concentration to remain elevated until our channel partner program and recurring utility and structural-protection customer relationships further mature.

 

Operating Expenses

 

   Nine months ended         
   September 30,         
   2026   2025   Change   % 
Cost of revenue  $1,201,385   $1,564,255    (362,870)   (23%)
Amortization and depreciation   370,354    241,700    128,654    53% 
General and administrative   907,140    743,101    164,039    22% 
Advertising and marketing   642,788    489,673    153,115    31% 
Payroll and management compensation   5,938,321    5,445,210    493,111    9% 
Professional fees   2,033,263    4,046,078    (2,012,815)   (50%)
Research and development expense   424,511    129,008    295,503    229% 
Total operating expenses  $11,517,762   $12,659,025    (1,141,263)   (9%)

 

 The decrease in operating expenses was primarily attributed to decreases in cost of revenue and professional fees offset by an increase in payroll and research and development expense.

 

Cost of revenue

 

   Nine months ended         
   September 30,         
   2026   2025   Change   % 
Cost of inventory  $1,017,584   $1,315,378    (297,794)   (23%)
Freight and shipping   14,466    21,724    (7,258)   (33%)
Consulting and advisory-related party   –    4,000    (4,000)   (100%)
Royalty and sales commission-related party   –    56,290    (56,290)   (100%)
Rent expense   169,335    166,863    2,472    1% 
Total cost of revenue  $1,201,385   $1,564,255    (362,870)   (23%)

 

During the nine months ended September 30, 2026, the cost of revenue decreased over the nine months ended September 30, 2025, primarily due to a decrease in cost of inventory and royalty and sales commission payments.

 

Cost of inventory consists of product costs, direct labor, related supplies, and direct testing of our CitroTech product and the various components required for installation of CitroSafe™ systems. Cost of inventory decreased during the nine months ended September 30, 2026, compared to the comparable 2025 period, primarily due to lower product sales volume and a decrease in outsource labor cost.

 

Freight and shipping relate to costs for shipping products to customers.

 

 

 

 38 

 

 

Consulting and advisory services are to a related party company for services related to product installations.

 

We did not have royalty and sales commissions to a related party in the nine months ended September 30, 2026. During the first quarter of 2025, we recognized $56,000 as an allocated portion of consulting and direct labor costs associated with our revenue as royalty and sales cost of revenue. In March 2025, we entered into a new contract under which the consulting and advisory royalty arrangement was terminated.

 

Rent expenses are warehouse and facility rent expenses. The increase in rent expense is primarily attributable to our relocation to a larger commercial facility for operations, warehousing, and customer-facing activities beginning in April 2025, along with the cancellation of a prior warehouse lease in May 2025.

 

Amortization and depreciation

 

Amortization and depreciation expenses are from the amortization of patents and technology and the depreciation of vehicles, furniture and equipment.

 

General and administrative

 

General and administrative expenses are office, rent, travel, insurance, website, IT, public listing fees, and other office related expenses. For the nine months ended September 30, 2026, we incurred increased expenditures on public listing fee, our website and IT development and travel as well as general office and insurance expenses from expansion of operations.

 

Advertising and marketing

 

The increase in advertising and marketing during the nine months ended September 30, 2026, over the nine months ended September 30, 2025, is primarily due to supporting revenue growth in addition to investor relations activities after being uplisted to the NYSE American. This includes rebranding efforts around the official company name change to CitroTech Inc. from General Enterprise Ventures Inc as well as the product labels moving from Mighty Fire Breaker to CitroTech and the conversion of relevant website and marketing materials. We attended and helped to fund events in the wildfire industry to expose leaders in the fire industry to the CitroTech product, which we believe will lead to sales in the future.

 

Professional fees

 

The professional fees during the nine months ended September 30, 2026, primarily included stock-based compensation of $526,000 to advisors and consultants, and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2026. In addition, we had expenses related to the formation of the HexiTech Joint Venture between CitroTech and Hexion that were a one-time expense. The professional fees during the nine months ended September 30, 2025, primarily included stock-based compensation of $2.7 million, of which $2.1 million was to a related party consultant (TC Special Investments, LLC (“TCSI”)) and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2025.

 

TCSI’s consulting services to us include sales and business development, customer relationship management, strategy optimization, investor relations, underwriter interface, coordinating outside counsel and other business aspects at the request of the Board of Directors. In addition to TCSI, stock-based compensation was remitted to certain individuals with fire retardant and industry experience, who provided guidance and insight to our management and Board of Directors with respect to the fire retardant and fire inhibitor industry, business development connections, and oversight during the testing and recognition processes.

 

 

 

 39 

 

 

Payroll and management compensation

 

During the nine months ended September 30, 2026, payroll and management compensation increased to $5.9 million from $5.4 million in the prior period. This increase was primarily attributable to higher payroll, reflecting a full period of compensation for the executive management team built out during 2025 and higher employee payroll. Management Compensation during 2026, primarily included stock-based management compensation of $3.8 million, and payroll to management of $1.1 million and employees of approximately $0.9 million. Compensation during 2025, primarily included stock-based management compensation of $4.1 million and payroll to management of $0.8 million and employees of $0.5 million.

 

Research and development costs

 

We continue to invest heavily in the testing and certifications of CitroTech treated products as well as in advance of submitting formulas for approval to apply product onto federal lands. We expect to continue growing R&D spend over historical spend as we add additional product lines and invest in the future of the company. This includes funded research programs with Texas A&M on new products that were not underway in 2025.

 

Other Expenses

 

For the nine months ended September 30, 2026 and 2025, the other expenses consisted of interest expense primarily related to convertible notes payable issued in 2025 of $975,000 and convertible notes payable issued in 2025 and 2024 of $2.6 million, respectively, change in fair value of derivative liability related to convertible notes payable issued in 2025 and 2024 of $0 and $2.0 million, respectively, financing expense of $0.4 million and $8.7 million, respectively, and loss on settlement of debt of $847,000 and $6.8 million, respectively. Settlement of debt in 2026 is the conversion of convertible notes issued in 2025. Settlement of debt in 2025 is conversion of convertible notes issued in 2024 and 2025. Financing expense is from 666,668 warrants granted to a financial advisor and 69,007 shares of Series C Convertible Preferred stock issued to BRH in 2025.

 

Net loss

 

The net loss for the nine months ended September 30, 2026 was approximately $12.4 million, a decrease of approximately $18.3 million as compared to the nine months ended September 30, 2025, primarily due to a significant reduction in other expenses and operating expenses, partially offset by lower revenue. 

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

Since our inception, we have incurred significant operating losses and negative cash flows from our operations. Our net loss was $12.4 million and $30.7 million for the nine months ended September 30, 2026 and 2025, respectively. In October 2026, we completed an equity offering which generated net proceeds of approximately $5.2 million. During fiscal year 2025, we completed a debt offering in February and an equity offering in September and October which generated net proceeds of approximately $3.7 million and $8.1 million, respectively.

 

 

 

 40 

 

 

Working capital

 

   September 30,   December 31,     
   2026   2025   Change 
Current assets  $2,342,767   $7,415,426   $(5,072,659)
Current liabilities  $782,922   $2,169,626   $(1,386,704)
Working capital  $1,559,845   $5,245,800   $(3,685,955)

 

As of September 30, 2026 and December 31, 2025, the current assets consisted of cash of $1.1 million and $6.3 million, respectively, inventory of $542,000 and $621,000, respectively, accounts receivable of $264,000 and $209,000, respectively, and prepaid expenses of $314,000 and $317,000, respectively, and deferred offering costs of $134,000 and $0, respectively.

 

As of September 30, 2026 and December 31, 2025, the current liabilities consisted of accounts payable and accrued liabilities of $590,000 and $316,000, respectively, deferred revenue of $12,000 and $3,000, respectively, due to related parties of $3,000 and $168,000, respectively, convertible notes net of discount of $0 and $219,000, respectively, convertible note – related party of $0 and $1.3 million, respectively, current portion of financing loan of $17,000 and $30,000 respectively, and current portion of operating lease liability of $162,000 and $148,000, respectively.

 

The decrease in working capital in 2026 was primarily due to a decrease in cash of $5.2 million for operating activities, offset by a decrease in convertible debt due to conversions into common stock.

  

Cash Flows

 

For the nine months ended September 30, 2026 and 2025

 

   Nine months ended     
   September 30,     
   2026   2025   Change 
Cash used in operating activities  $(5,243,393)  $(3,386,432)  $(1,856,961)
Cash used in investing activities  $(9,027)  $(221,670)  $212,643 
Cash provided by financing activities  $72,530   $9,028,943   $(8,956,413)
Net Change in cash  $(5,179,890)  $5,420,841   $(10,600,731)

 

Operating Activities

 

We have not generated positive cash flows from operating activities.

 

For the nine months ended September 30, 2026, net cash flows used in operating activities consisted of a net loss of $12.4 million, reduced by stock-based compensation of $4.7 million, non-cash lease expenses of $117,000, amortization and depreciation of $370,000, amortization of debt discount of $892,000, loss on settlement of debt of $847,000, loss on disposal of equipment of $32,000, and reduced by bad debt recovery of $20,000, and net changes in operating assets and liabilities of $211,000.

 

 

 

 41 

 

 

For the nine months ended September 30, 2025, net cash flows used in operating activities consisted of a net loss of $30.7 million, reduced by stock-based compensation of $15.4 million, non-cash lease expenses of $123,000, amortization and depreciation of $242,000, amortization of debt discount of $2.2 million, loss on settlement of debt of $6.8 million, write-off of deferred offering cost of $197,000 and changes in derivative liability of $2.0 million, and reduced by net changes in operating assets and liabilities of $328,000. 

 

Investing Activities

 

For the nine months ended September 30, 2026 and 2025, the net cash flows used in investing activities consisted of the purchase of equipment of $22,000 and $222,000 and sales of equipment of $12,500 and $0, respectively. 

 

Financing Activities

 

For the nine months ended September 30, 2026, net cash provided by financing activities consisted of $96,000 capital contribution from a related party and proceeds from the exercise of warrants of $25,000, $15,000 deferred offering cost payment and repayment of a financing loan of $33,000.

 

For the nine months ended September 30, 2025, net cash provided by financing activities consisted of $5.7 million from the issuance of Series C Convertible Preferred Stock, $3.7 million from the issuance of convertible promissory notes and associated warrants, $71,000 deferred offering cost payment, repayment of a financing loan of $216,000 and repayments to related party of $25,000.

 

Contractual Obligations

 

Financing loans

 

We had a financing loan for the purchase of a vehicle in September 2025. The loan repayment is $2,021 per month for 60 months, beginning October 2025, with an interest rate of 11.33%.

 

Lease Agreements

 

We have one lease classified as an operating lease for office and warehouse purposes. The following table outlines maturities of our lease liabilities as of September 30, 2026: 

 

Year ending December 31,    
2026 (remaining three months)  $49,327 
2027   203,228 
2028   211,357 
2029   219,812 
2030   55,486 
Thereafter   – 
    739,210 
Less: Imputed interest   (83,254)
Operating lease liabilities  $655,956 

 

 

 

 42 

 

 

Liquidity

 

We have incurred losses since inception and incurred a net loss of $12.4 million during the nine months ended September 30, 2026. As of September 30, 2026, we had cash of $1.1 million. On October 22, 2026, subsequent to the end of the quarter, we closed an underwritten public offering of 2,240,000 shares of common stock at a public offering price of $2.50 per share, which generated net proceeds of approximately $5.2 million after deducting underwriting discounts and commissions and offering expenses payable by us.

 

We believe that our existing cash resources will be sufficient to fund our planned operations through the majority of 2027, with a high dependency on actual product sales. To more rapidly grow our revenue and continue operations beyond such time frame, we will be required to raise additional funds by completing additional equity or debt offerings or increasing revenue. We may also raise capital through public or private offerings of equity or debt securities or by entering into a credit facility. There can be no assurance that we will be successful in acquiring additional funding, that our projections of our future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.

 

Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to us, but which will only be resolved when one or more future events occur or fail to occur. In consultation with its legal counsel as appropriate, our management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we, in consultation with legal counsel, evaluate the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in our financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is likely, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

 

Critical Accounting Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), which require management to make estimates, judgments and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes.

 

For a discussion of our critical accounting estimates, refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026 (the “Annual Report”). There have been no material changes to our critical accounting estimates as described in that Annual Report.

 

 

 

 

 43 

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information specified under this item.

 

Item 4. Controls and Procedures.

 

Management’s Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were effective as of September 30, 2026 to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

  

Changes in Internal Controls over Financial Reporting

 

There has been no change in the Company’s internal control over financial reporting during the three months ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. Management will continue to monitor and evaluate the effectiveness of our internal controls over financial reporting on an ongoing basis and is committed to taking further action and implementing additional improvements as necessary.

 

 

 

 

 44 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business, financial condition, and results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

Item 1A. Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Quarterly Report. For a discussion of risks that could affect our business, see the “Risk Factors” section of the Annual Report and the “Risk Factors” section of our prospectus dated October 21, 2026, filed with the SEC pursuant to Rule 424(b)(4). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended September 30, 2026, the Company issued 205,206 unregistered shares of Common Stock and 25,000 common stock warrants as follows:

 

  · 3,000 shares of Common Stock issued to a consultant for services, valued at $16,800;
  · 37,500 shares of Common Stock issued upon vesting of restricted stock;
  · 164,706 shares of Common Stock issued upon the cashless exercise of 166,667 warrants; and
  · 25,000 warrants issued to a consultant for services, valued at $65,677.

 

The offer and sale of the above securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuances did not involve a public offering.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not Applicable.

 

Item 5. Other Information.

 

(a) None.

 

(b) None.

 

(c) During the quarter ended September 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 45 

 

 

Item 6. Exhibits.

 

    Incorporated by Reference

Exhibit

Number

  Exhibit Description   Form   Exhibit   Filing Date/
Period End Date
3.1   Articles of Domestication/Articles of Incorporation   10-K   3.1   04/15/2024
3.2   Amendment to Articles of Incorporation   10-K   3.2   03/31/2025
3.3   Amendment to Articles of Incorporation   8-K   3.1   09/10/2025
3.4   Amended and Restated Bylaws   10-Q   3.4   11/12/2025
3.5   Second Amended and Restated Designations and Preferences of Series A Preferred Stock   10-K   3.4   03/31/2025
3.6   Amended and Restated Designations and Preferences of Series C Convertible Preferred Stock   10-K   3.5   03/31/2025
3.7   Articles of Amendment to the Articles of Incorporation   8-K   3.1   01/28/2026
3.8   Certificate of Name Change   8-K   3.2   01/28/2026
10.1   Amendment No. 1 to Stock Exchange and Stockholders Agreement, dated September 14, 2026, by and between CitroTech Inc. and BoltRock Holdings, LLC   8-K   10.1   09/14/2026
10.2   Amendment No. 1 to Stock Exchange and Stockholders Agreement, dated September 14, 2026, by and between CitroTech Inc. and TC Special Investments LLC   8-K   10.2   09/14/2026
31.1*   Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            
31.2*   Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002            
32.2**   Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002            
101.INS*   Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.            
101.SCH*   Inline XBRL Taxonomy Extension Schema Document            
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document            
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document            
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document            
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document            
104*   Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.            

________

* Filed herewith.

**Furnished herewith.

 

 

 

 

 46 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CitroTech Inc.  
       
Dated: November 10, 2026 By: /s/ Nanuk Warman  
    Nanuk Warman  
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 47 

 

Keep reading